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THE EFFECT OF GLOBAL CONTROL ELEMENTS ON THE 
EXPRESSION OF A NOVEL  GNTR TYPE REGULATOR yvfI IN B. 
SUBTILIS  
SUMMARY 
Bacilysin is a dipeptide antibiotic consisted of L-alanin and L-anticapsin, and 
produced extracellularly by certain species of Bacillus subtilis. Previously, we have 
shown that bacilysin biosynthesis was under the control of quorum sensing 
mechanism involving in the actions of ComQ/ComX, ComP/ComA, PhrC(CSF) and  
Spo0K(OppA). The disruption of lipopeptide antibiotic surfactin biosynthetic (srfA) 
operon in the bacilysin producer resulted in a bacilysin-negative phenotype, thus our 
study verified that the srfA operon functions directly in the production of bacilysin. 
The loss of bacilysin production in spo0H and or spo0A-blocked mutants as well as 
an increase in the production of bacilysin in abrB-disrupted mutants and the 
suppression of bacilysin-negative phenotype by an abrB mutation in spo0A-blocked 
mutants revealed that the transcription of some gene(s) involved in bacilysin 
formation is under the negative control of abrB gene product which is relieved by 
Spo0A protein. Recently, we identified a novel gene, namely yvfI required for the 
production of dipeptide antibiotic bacilysin. This gene encode a product resembling 
GntR family transcriptional regulator. 
As a further work, the main purpose of the present study is to elucidate the effects of 
previously identified regulatory genes oppA, comP, comA, phrC, phrK, phrF, comQ 
(comX), srfA, codY, degU, sigB, spo0A, spo0H and abrB on the transcriptional factor 
encoding gene yvfI. Firstly, to analyze the expression of yvfI, a B. subtilis strain, 
namely TEK7, containing a transcriptional PyvfI-lacZ  fusion at the  yvfI locus was 
constructed. Subsequently, each of the regulatory genes indicated above was 
disrupted in the transcriptional yvfI–lacZ fusion bearing strain TEK7. The resulting 
mutant strains and TEK7 as the control were cultured in PA medium and yvfI- 
directed β-galactosidase activities were monitored. Mutations in comP, comA, 
comQ(comX), phrC, phrK ,phrF, srfA, spo0H and spo0A genes completely abolished 
yvfI-lacZ expression. abrB null mutation gradually relieved the repression of yvfI 
during exponential phase while decreasing the induced level of expression in the 
stationary phase. However complete inhibition of yvfI expression in ∆spo0A strain 
was not restored by abrB mutation. During exponential phase yvfI-lacZ expression in 
codY mutant strain was not significantly affected, but yvfI expression in the 
stationary phase was not induced to maximal level as in the case of wild type. 
However, abrB-codY double mutations resulted in a significant  elevation in  yvfI-
lacZ expression. In this study, we also found that yvfI expression is subject to 
nutritional repression mediated by Casamino acids. The effects of a transition 
regulator gene degU and general stress control element sigB gene on yvfI expression 
were also investigated and we found yvfI expression to be positively regulated by 
DegU. However, SigB  had no effect on yvfI expression.  
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GLOBAL KONTROL ELEMANLARININ B. SUBTİLİS’ TE YENİ BİR 
GNTR TİPİ DÜZENLEYİCİ GEN OLAN yvfI’ NIN GEN İFADESİ 
ÜZERİNDEKİ  ETKİLERİ 
ÖZET 
Belirli bazı Bacillus subtilis suşları tarafından sentezlenen hücre dışı bir antibiyotik 
olan bacilysin L-alanin ve L-antikapsin’den oluşmuş bir dipeptiddir. Daha önceki 
çalışmalarımızda, basilisin biyosentezinin, ComQ/ComX, ComP/ComA, PhrC(CSF) 
ve Spo0K(OppA)’ nın aktivasyonunu etkileyen quorum sensing mekanizmasının  
kontrolü altında olduğu gösterilmiştir. Basilisin üretebilen suşta lipopeptid 
antibiyotik surfactin biyosentetik (srfA) operonunun inaktive edilmesi sonucu 
basilisin üretemeyen fenotipin oluşmasıyla, bizim çalışmamızda srfA operonunun 
basilisin üretiminde doğrudan görev aldığı doğrulanmıştır. spo0H ve/veya spo0A 
genlerinin bloke edildiği  mutantlarda basilisin üretilememesi, abrB geni bozulmuş 
mutantlarda basilisin üretiminde artış gözlenmesi, spo0A bloke edilmiş mutantlarda 
abrB geninin mutasyonu sonucu basilisin üretemeyen fenotipin ortadan kalkması, 
basilisin oluşumunda görev alan bazı gen veya genlerin transkripsiyonunun, abrB 
gen ürününün negatif kontrolü altında olduğunu ve bu negatif etkinin Spo0A 
tarafından düzeltilebileceğini ortaya koymuştur. Yakın bir zamanda, çalışma 
grubumuz  dipeptid antibiyotik basilisin üretimi için gerekli olduğu belirlenen ve yvfI 
olarak adlandırılan yeni bir gen tanımlamıştır. Bu gen GntR transkripsiyonal 
düzenleyici ailesine benzeyen bir ürün kodlamaktadır.  
Yapılan bu çalışmaların devamı olan şimdiki çalışmamızın temel amacı, daha önce 
etkileri tanımlanmış olan oppA, comP, comA, phrC, phrK, phrF, comQ (comX), srfA, 
codY, degU, sigB, spo0A, spo0H ve abrB regülator genlerinin yvfI tarafından 
kodlanan transkripsiyonel faktör üzerindeki etkileri aydınlatılmaya çalışılmıştır. 
Öncelikle, yvfI gen ifadesini analiz etmek için, yvfI lokusunda transkripsiyonel PyvfI-
lacZ füzyonu içeren ve TEK7 olarak adlandırılan bir B. subtilis suşu oluşturulmuştur. 
Daha sonra, yukarıda belirtilen düzenleyici genlerden her biri transkripsiyonel yvfI–
lacZ füzyonu taşıyan TEK7 suşunda bloke edilmiştir. Elde edilen mutantlar ve 
kontrol grubu olan TEK7, PA besiyerinde büyütülmüş, yvfI’ ya bağlı spesifik β-
galaktozidaz aktivititeleri gözlenmiştir. comP, comA, comQ(comX), phrC, phrK, 
phrF, srfA, spo0H ve spo0A genlerindeki mutasyonlar yvfI-lacZ gen ifadesinin 
tamamen bozulmasıyla sonuçlanmıştır. abrB mutasyonu eksponensiyel büyüme fazı 
sırasında yvfI baskılanmasını kısmen hafifletmiş, durağan fazdaysa var olan gen 
ifadesi baskılanmıştır, buna karşılık ∆spo0A mutant suşunda tamemen engellenen 
yvfI gen ifadesi abrB mutasyonuna rağmen eski haline getirilememiştir. codY mutant 
suşunda yvfI-lacZ gen ifadesinin eksponensiyel büyüme fazı sırasında belirgin olarak 
değişmemiş olduğu, fakat durağan faz sırasında yabani suşun ulaştığı ekspresyon 
seviyesine ulaşamadığı görülmüştür. Bununla birikte, abrB-codY çift mutasyonu 
yvfI-lacZ gen ifadesinde önemli bir artış ile sonuçlanmıştır. Bu çalışmada, yvfI gen 
ifadesinin kazamino asit varlığında besinsel baskılamaya da maruz kaldığı 
bulunmuştur. Bir geçiş evresi düzenleyici gen olan degU ve genel stres kontrol 
elemanı olan sigB genlerinin de yvfI gen ifadesi üzerine etkileri araştırılmış ve DegU 
ürünün yvfI gen ifadesi üzerinde pozitif düzenleyici etkiye sahip olduğu bulunmuştur. 
 xiv
Bunun yanısıra,  SigB sigma faktörünün yvfI gen ifadesi üzerine hiçbir etkiye sahip 
olmadığı görülmüştür. 
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1.  INTRODUCTION 
1.1 Bacillus subtilis 
Bacillus subtilis is an unusual endospore-forming rhizobacterium that can produce 
ribosomally and non-ribosomally more than twenty-four types of antibiotics along 
with other secondary metabolites that have antibacterial, antifungal and 
antimetabolic properties. Bacillus subtilis shows excellent genetic adaptional abilities 
that allow the bacterium to grow up in many diverse environments such as soil on 
plant roots, aquatic habitats, even gastrointestinal tracts of marine and terrestrial 
animals. Until recently, it was accepted as an obligate aerob organism but these new 
studies showed that it can be isolated from animal’s feces that are fed with plants 
associated with B.subtilis. Furthermore, observation of putative respiratory nitrat 
reductase genes has strengthened the proposition that B.subtilis can live in anaerob 
conditions (Glaser et al., 1995; Ramos et al., 1995; Earl et al., 2008). 
Following the sequencing of its genome, B.subtilis became a very widely studied 
model organism due to its non-pathogenicity, its characteristic of being practical for 
harvesting and its ability for yielding plenty of industrially important products such 
as macrolmolecular hydrolases (proteases and carbohydrases), other specific 
enzymes (e.g. α-amylases, β-amylases) and many antibiotics (Kunst et al., 1997). 
Beside of its well-known genome structure and basic nutritional requirements, 
Bacillus subtilis represents a preferred Gram-positive bacterium for molecular and 
genetic surveys because of its crucial feature of genetic competence (Marten et. al., 
2000; Stein, 2005). 
Additionally, exhibiting probiotic property, B.subtilis is  also cosidered as a good 
candidate for a novel prophylactic, therapeutic, and growth promoting agent as an 
alternative to antibiotics (Hong et al., 2004; Williams 2007).  
Moreover, B. subtilis is a chemoorganotroph which has surviving ability when 
exposed to limited growth conditions such as media including only salt, glucose or 
one of the other sugars for carbon and energy source and also nitrogen (Nicholson  
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and Setlow, 1990). Furthermore, B. subtilis, as similar to many other members of this 
genus, is mesophilic and may grow as normal-sized colonies within a day in a 
suitable temperature, 37oC (Harwood et al., 1990). 
In case of nutritional limitation or other unfavorable environmental conditions, cells 
initiate many distinct adaptative responses in order to survive. Under those 
conditions, cells of  B.subtilis become not only organized for motility, chemotaxis 
and genetic competence allowing uptake of exogenious DNA, but also use its 
‘weapons’ such as degradative enzymes and antibiotics in order to metabolize 
alternative nutrients and to  eliminate other bacteria to take advantage for nutrient 
competition, respectively (Hamoen et al., 2003). The sporulation process is the last 
resort of cells to keep surviving, such that sporulating cells are divided as a mother 
cell and smaller forespore cell, then as a result of complex regulatory  circuits, 
resistant mature spore is generated (Banse et al., 2008). 
Total genome of Bacillus subtilis is 4.214.810 bp long consisted of 4.100 protein-
coding genes (Kunst et al., 1997). 271 (%6,6) of these genes are indispensable 
including 25 (%4) genes with unknown function, 3830 (%94,4) are non-essential 
(Kobayashi et al., 2003).  The genome of Bacillus subtilis encodes for 17 sigma 
factors and about 250 transcriptional regulators that bind to DNA, in addition, 86 
tRNA, 30 rRNA and 3 small stable RNA encoding genes (Kobayashi and 
Ogasawara, 2002). 
1.2 Quorum Sensing Mechanism As A Regulatory System of Gene Expression 
Bacteria was thought as a non-cooperative, unable to connect to each other 
unicellular organism until an hormone-like extracellular product has been discovered 
that is produced to assist regulation of competence in Streptococcus pneumoniae 
(Tomasz, 1965; Bodman et al., 2008). When intercellular communication called as 
“quorum sensing” was detected firstly in bioluminescent marine bacterium Vibrio 
fischeri by following surveys of Nealson and colleagues in 1970 (Nealson et al., 
1970; Nealson and Hasting, 1979), the vision for understanding of bacterial existence 
has tended to shift from that bacterial cells are non-interactive to the acception that 
they can act as multicellular organisms and exhibit social behaviors (Williams, 2007; 
Bodman et al., 2008).  
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Quorum sensing mechanism is used by many diverse bacterial species for 
establishing different bacterial behaviors such as coordination of population to search 
for nutrients and to adapt to special environmental conditions, to defend itself 
aigainst other competitors, and to run away from the locations where vitae of 
population is at risk (Lazdunski et al., 2004). Cellular processes that regulated by 
quorum sensing, exhibit differences in each bacterial species.  For instance, the QS 
system is used for virulence and biofilm formation in Pseudomonas aeruginosa, 
bioluminescence in Vibrio fischeri and Vibrio harveyi, antibiotic production in 
Erwinia carotovora; virulence developing in Staphylococcus aureus and 
Enterococcus faecalis, genetic competence development in Streptococcus 
pneumoniae and sporulation, also genetic competence in Bacillus subtilis (Lazazzera, 
2000, Bodman et al., 2008). Several fundamental genes for signal synthesis and 
transduction and also diffusable small signal molecules(called as pheromones or 
autoinducers) are assigned in QS circuit (Camara, 2006). Because of diffusable 
features of the signal molecules, QS mechanism regulate not only its own cells, 
intraspeciesly, but also the cells of the other species, interspeciesly,  and the cells of 
bacteria and higher organisms, inter-kingdomly (Diggle et al., 2007). Quorum 
sensing is a density-dependent cell-signaling mechanism, therefore, when QS 
signaling molecules are secreted from the cell into the external environment, they are 
sensed by the ‘neighbouring cells’. Depending on increased bacterial population 
density, produced QS signal molecules accumulates and their concentration reaches 
to a threshold level. After this point, a population-wide response is generated by 
signal transduction cascade which activates repression or induction of QS-dependent 
target genes (Schauder et al., 2001; Winans and Bassler, 2002). 
QS signals employed  in QS circuits are chemically different elements although their 
functions are same. In Gram(-) bacteria very small molecules(<1000 Da), called as 
acylated homoserine lactone derivatives are attended in QS circuits. In contrast, 
small oligopetides with 5 - 20 aminoacids that usually contain chemical modification 
are used by Gram(+) bacteria as signaling. After reaching the adequate cell density, a 
target sensor kinase or response regulator is activated.  
Among Gram-positive bacteria, Bacillus subtilis is a well known example in order to 
understand the signaling and regulation mechanism managed through a cell-density 
dependent manner (Griffith and Grossman 2008). At the end of the exponential 
 4 
growth phase, if nutrients are limited for optimal growth, B. subtilis cells use a 
complex motility and chemotaxis system in order to search for nutrients in the 
environment. If nutritional limitation continues, after transition to the stationary 
growth phase, degradative enzyme production is initiated, such as proteases to 
liberate nutrients from alternative resources that are normally difficult to access. In 
addition to proteases, also antibiotics are synthesized in order to eliminate possible 
competitors. Prolonged nutritional stress is resulted with genetic competence 
development and lastly sporulation of the bacterial population (Hamoen et al., 2003). 
These general quorum responses are regulated by extracellular signaling peptides 
accumulated in growth medium (Lazazzera, 2000). Until now, identified signaling 
peptides for Bacillus subtilis are classified as three classes (Auchtung et al., 2006); 
ComX, a modified 10-amino-acid peptide interacting with its receptor, 
extracellularly (Magnuson et al., 1994; Piezza et al., 1999), lantibiotic peptides 
which interact extracellularly with their receptors (Stein 2005) and lastly 
pentapeptides, also called as Phr peptides inhibiting the activity of their target 
proteins, known as Rap proteins (Lazazzera 2001; Perego et al., 2001). 
Although ComX pheromone was firstly described as a part of competence 
development regulation, now it appears not only to be a general indicator of high cell 
density, but also the a regulatory protein involved in regulation of many genes 
(Dunny and Winans, 1999). ComX pheromone is a ten amino acid peptide 
(ADPITRQWGD) including a hydrophobic modification on tryptophan residue 
(Magnuson et al., 1994). ComX is encoded by comX as a 55-amino acid precursors. 
comQ located upstream of comX gene in the chromosome, is speculated as 
responsible for modification or processing of ComX pheromone precursors to 10-
amino acids ComX pheromone (Schneider et al., 2002).  After cleavage and 
modification by ComQ, then it is exported to the extracellular environment when 
population density is increased. comQ and comX are required for fully activation and 
maturation of ComX pheromone (Ansaldi et al., 2002). ComX pheromone requires 
two-compenent system encoded by comP and comA (Weinrauch et al., 1990). ComX 
binds to its cognate membrane-bound histidine kinase receptor ComP, concluded in 
the activation of ComP via autophosphorulation at a conserved histidine residue. 
Activated ComP~P then donates its phosphate to ComA, a phosphorylation-
dependent response regulator transcription factor, on a conserved aspartate residue 
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(Pottathil et al., 2008). Then, phosphorilated ComA transcription factor initiates 
many biological processes as a result of transcription of at least nine operons 
involved in the development of competence and in the production of degradative 
enzymes and antibiotics in response to increasing population density. Extracellular 
peptide signaling is used to coordinate the activity of ComA according to 
concentration level (Tortosa and Dubnau, 1999). At low signal peptide concentration 
ComA is inactive. When increasing of signaling peptide concentration then ComA is 
actived (Griffith and Grossman, 2008). 
 
                                                                         
 
 
 
 
Figure  1.1 :  Regulation mechanism of quorum responses triggered by 
environmental signals and initiation of signal transduction 
cascade through  ComX and CSF diffusible peptides (Lazazzera, 
2000).                                       
There are also the other cell-density dependent signaling peptides effective on ComA 
activity which are secreted into growth medium and transported via oligoppeptide 
permease in order to act on their target intracellularly (Griffith and Grossman, 2008). 
ComA activation is tightly regulated by those pentapeptides and their target proteins 
(phosphatates) so that at low concentration of signaling peptides, ComA could not be 
activated for initiation of target genes expression  (Pottathil and Lazazzera, 2003).  A 
set of Phr peptides including PhrA, PhrC, PhrE, PhrF, PhrG, PhrH, PhrI and PhrK 
and also a set of Rap proteins consisted of 11 members from RapA to RapK are 
encoded by B.subtilis via an autoinducible operon system. Seven of this rap genes 
are located in an operon with a downstream overlapping phr genes so that each Phr 
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protein is encoded together with a cognate Rap protein at the same time (Perego et 
at., 1996; Kunst et al., 1997; Jiang et al., 2000; Bongiorni et al., 2005). In addition, 
phr genes include a promoter in the upstream region of phr providing recognition site 
for RNA polymerase carrying an alternative subunit, σH, encoded by spo0H. So 
expression of phr genes via σH leads to accumulation of Phr peptides in the transition 
state from exponential phase to stationary phase (Auchtung et al., 2006). 
In addition to master extracellular signaling peptide ComX, the CSF peptide (PhrC) 
also play a key role on stimulating ComA activity. The effects of CSF on ComA 
regulation is more complicated than that of ComX pheromone. PhrC (ERGMT), also 
known as CSF, is a diffusable pentapeptide encoded from rapC-phrC operon, 
encoding CSF and its cytoplasmic receptor RapC. When CSF reaches a critical 
concentration, it is transported back into the cell by an oligopeptide permease 
(Spo0K), an ATP-binding casette transporter (Pottathil et.al., 2008). Transported 
CSF then binds to two different intracellular receptors to modulate the activity of the 
ComA transcription factor according to intracellular CSF concentration level 
(Perego, 1997; Lazazzera and Grossman, 1998). While CSF concentration is lower 
(1–5 nM) at the onset of growing,  CSF stimulates the activity of ComA for the 
expression of ComA~P dependent genes by inhibiting the activity of a putative 
ComA~P phosphatase, RapC (Schneider et al., 2002). At higher concentrations (>20 
nM), CSF interacts with its cognate receptor to prevent the expression of ComA-
dependent genes (Lazazzera et al., 1997). Beside these two functions of CSF, at high 
concentrations, sporulation is also triggered by CSF by inhibiting the activity of an 
alternate aspartyl-phosphate phosphatase, RapB (Lazazzera, 2000). On the other 
hand, it was proposed that CSF might be responsible for modulating the quorum 
response rather than induce it (Lazazzera and Grossman, 1998). Excistance of a 
binding site for sigma H (σH) on the promoter region of phrC-rapC operon  signals 
that its production is regulated by starvation (Carter et al., 1991) and sigma H is 
active during the transition state from exponential phase to stationary phase  (Healy 
et al., 1991), so that under starvation conditions, ComA-dependent genes which 
might be required for transition into stationary phase could be controlled even though 
in case of low cell density and therefore, CSF is an indicator not only for cell-density 
but also for starvation (Lazazzera et al., 1999; Lazazzera 2000).         
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Also sporulation is regulated by Spo0A transcription factor as a response to changing 
signal transduction (Hoch, 1993), like a reaction against depletion of a carbon or 
nitrogen source, or against phosphate starvation under some conditions (Waldburger 
et al., 1993). In order to activate this protein, phosphorylation is required and the 
level of Spo0A phosphorylation is regulated by the phosphorelay signal transduction 
system (Burbulys et al., 1991).  
On the quorum sensing mediated sporulation mechanism, signaling peptides have 
key roles and act as spore factors (Waldburger et al., 1993). After a threshold level 
for PhrA (ARNQT) and PhrC (CSF) (>20nM), which are encoded as precursors and 
activated when exported from the cell, they are imported by the oligopeptide 
transport system (Opp) into the cell again in order to inhibit RapA and RapB 
targetting Spo0F~P (Perego et al., 1994) and also PhrE supports for  inhibition of 
RapE acting on Spo0F. Among at least seven extracellular peptides encoded by phr 
genes, the function of extracellular PhrC is obvious; it is an indicator not only for cell 
density, but also the other physiological conditions. It is also obvious PhrA is a part 
of cell-cell signaling but it is suggested that PhrA involved in a timing mechanism 
via cell-autonomous signaling for the control of initiation of sporulation rather than 
critical extracellular accumulation (Perego et al., 1997) 
 
 
 
 
 
      
 
 
Figure 1.2 : A model for efficiency mechanism of signaling peptides and  
phosphatates involved in quorum response in B.subtilis (Pottathil and 
Lazazzera, 2003). 
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1.3. Bacilysin : A Dipeptide Antibiotic  
Bacilysin is one of the simplest peptide antibiotic produced and secreted 
extracellularly by certain strains of Bacillus subtilis. Its small (125 kDa) and basic 
structure is consisted of L-alanine at N-terminus and L-anticapsin, an unususal 
aminoacid, at C terminus and (Walker and Abraham, 1970). Antibiotic activity is 
effective against bacteria and fungi, mainly Candida albicans. 
          
Figure 1.3 :  Chemical structures of bacilysin and anticapsin respectively (Walker 
and Abraham, 1970). 
Anticapsin moiety of bacilysin is the basis of its antibiotic activity (Whitney et al., 
1972). The antibiotic is transported into susceptible cells by a special peptide 
permease system and hydrolyzed to L-alanine and L-anticapsin by peptidases. Then 
intracellular anticapsin prevents the activity of glucosamine synthetase assigned for 
bacterial peptidoglycan and fungal mannoprotein biosynthesis (Perry and Abraham 
1979; Chmara et al., 1981). This blockage is resulted with protolasting and lysing of 
host cells (Whitnney and Funderburk 1970; Kenig et al., 1976; Chmara et al., 1982; 
Chmara 1985). On the basis of its metabolic target, anticapsin becomes specifically 
antagonized by glucosamine or N-acetylglucosamine (Walton and Rickes 1962; 
Kenig and Abraham 1976). 
Prephenate belonging to the aromatic amino acid pathway is the primary precursor of 
anticapsin biosynthesis (Hilton et al., 1988) and ligation of the peptide bound with L-
alanine proceeds in an enzymatic reaction for catalysation  by an amino acid ligase, 
bacilysin synthetase (Sakajoh et al. 1987). 
Bacilysin production of B.subtilis is a growth-dependent phenomenon in a synthetic 
media and under the control of nutritional and feedback regulation. In the presence of 
certain nutrients, such as glucose or casaminoacids, and/or physiological factors, like 
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pH, temperature, biosynthesis of bacilysin is inhibited (Özcengiz et al., 1990; 
Özcengiz and Alaeddinoglu, 1991; Basalp et al., 1992). Also its biosynthesis is under 
global quorum-sensing control system via the OppA (Spo0K), the transporter 
element, and Opp-imported peptide pheromone PhrC, which is necessary for 
efficient sporulation and competence development (Yazgan et al., 2001). Besides 
ComQ/ComX, PhrC (CSF), ComP/ComA  and  also  their  unique transporter Spo0K 
(Opp), products of srfA, spo0A, spo0H and abrB genes are defined as parts of 
quorum-sensing mechanism and have key roles on regulatory circuit of  bacilysin 
biosynthesis (Karataş et al., 2003). 
The ywfBCDEFG gene cluster of B.subtilis, renamed as bacABCDE, carries 
biosynthetic core functions on bacilysin production (Steinborn and Hofemeister 
1998/2000; Inaoka et al., 2003).  Each gene of the operon has specific functions; 
bacABC (ywfBCD) encode proteins functioning in the biosynthesis of anticapsin, 
bacD (ywfE ) in the (amino acid) ligation of anticapsin to alanine and bacE (ywfF), in 
self-protection from bacilysin. ywfB and ywfG encode a prephenate dehydratase and 
an aminotransferase which are employed in anticapsin production because of 
prephenate of the aromatic amino  acid pathway (Hilton et al., 1988; Inaoka et al.,  
2003; Steinborn et al., 2005).  
Even though ribosomal peptide synthesis, driven by aminoacyl tRNA synthetase is 
conserved for all cellular organisms, large multienzyme complex functioning in a 
thiotemplate mechanism in a pathway initiated by a protein template is specific to 
prokaryotic organisms for producing antimicrobial peptie synthesis. Until recentely, 
it was thought that bacilysin formation was carried out by multiple-carrier 
thiotemplate mechanism. However, its biosynthesis mechanism was not fully 
coupled to non ribosomal peptide synthetase (NRPS) mechanism due to the fact that 
adenylation and thiolation were evident only for L-alanine, but not for L-anticapsin 
(Marahiel, 1997; von Döhren  et al., 1999). Besides, very recently ywfE was 
announced as a novel gene synthesizing L-amino acid ligase belonging to ATP-
dependent carboxylate-amine/thiol ligase superfamily which is known to contain 
enzymes catalyzing the formation of various types of peptide.  
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Figure 1.4 :   The bacilysin gene cluster organisation, bacABCDE,  relative to open 
                       reading frames ywfABCDEFG of Bacillus subtilis 168. DNA sequence 
is among 3875148–3867678 bp in the chromosome obtained from 
SubtiList database R16.1 (Kunst et al., 1997). Proposed terminator 
(T0) elements are indicated according the SubtiList database. Sigma A 
promoter (P) elements_35 (TTGACA) and _10 (TAAAATt) were 
detected 56 bp and 33 bp upstream of the ATG codon of the bacA 
gene (Steinborn et al., 2005). 
 
Additionally, bacilysin formation is under dual regulation of guanosine 5’-
diphosphate 3’-diphosphate (ppGpp) and guanosine triphosphate (GTP) affecting 
bacABCDE operon as a part of stringent response via Cod-Y mediated manner 
(Inaoka et al., 2003). The CodY regulon encodes extracellular degradative enzymes, 
transporter proteins, catabolic enzymes, factors involved in genetic competence, 
antibiotic synthesis pathways, chemotaxis proteins, and sporulation proteins and 
those genes and/or operons are under negative regulation of CodY in the presence of 
excessive glucose or casamioacids (Ratnayake-Lecamwasam et al.,2001; Shivers and 
Sonenshein 2004). On the other hand, CodY regulatory protein also acts as a positive 
regulator by sensing intracellular level of GTP under carbon source or amino acid 
limitation conditions, then stringent response is activated.  In the stringent response, 
the product of relA gene called as stringent factor (ppGpp synthetase) synthesizes 
hyperphosphorylated guanosine nucleotides [(p)ppGpp] from GTP, namely GTP is 
conversed to pppGpp and ppGpp. Accumulation of   (p)ppGp leads to inhibition of 
the activity of IMP dehydrogenase, the first enzyme involved in GMP synthesis 
pathway, so that GTP production level is blocked (Cashel et al. 1996). This transient 
increase of (p)ppGpp results with induction of spore formation in relA+ (stringent) 
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cells but not in relA- (relaxed) mutant cells (Ochi et al., 1982; Ochi and Freese, 
1983). Furthermore, this decrease in intracellular GTP level creates a signal for 
inactivation of CodY and activation of CodY-repressed genes whose products allow 
adaptation to nutrient depletion (Serror and Sonenshein, 1996; Ratnayake-
Lecamwasam et al.,  2001; Inaoka et al., 2003; Molle et al., 2003). 
Beside CodY, the pleiotropic AbrB protein is known to play a key role in regulating 
numerous transition state genes expressed at the onset of entry into stationary phase, 
at the end of exponential phase which is also involving antimicrobials production in 
B. subtilis, such as sublancin, subtilosin A, bacilysocin, bacilysin, the SdpC 
sporulation delay toxin, the SkfA sporulation killing factor, and the spore-associated 
antimicrobial polyeptide TasA (Zheng et al., 1999; Stöver and Driks, 1999; Philips 
and Strauch, 2002; Karataş et al., 2003; Stein 2005; Strauch et al., 2007). Another 
regulatory protein, Spo0A, is phosphorylated by a complex phosphorelay system 
during the transition state (Burbulys et al., 1991; Hoch, 1995;). Increased level of 
activated Spo0A~P by phosphorulation results with higher DNA-binding affinity to 
the abrB promoter and hence more efficient repression of abrB transcription (Strauch 
et al., 1990; Klein and Marahiel, 2002). Dropping of intracellular level of AbrB 
below a critical threshold rate is resulted in relieving of  AbrB-dependent repression   
upon the production of the various antimicrobials,  antibiotic and the other stationary 
phase-associated products (Strauch 1993; Strauch an Hoch, 1993). 
               
Figure 1.5 :    Antibiotic biosynthesis pathway of B. subtilis  involved in subtilin, 
subtilosin, surfactin and bacilysin. Skf acts as a the killing factor and 
TasA is the spore-associated antimicrobial polyeptide (Stein, 2005). 
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srfA is an operon required for the production of the lipopeptide antibiotic surfactin, 
competence development, and efficient sporulation in Bacillus subtilis. Expression of 
this operon is induced following the onset of stationary phase and regulated by 
specific regulatory genes comP, comA, and spo0K. Based on the location of srf  in 
the regulatory pathway, it gives rise to ideas that it is an intermediate which senses 
an environmental condition and responds to it by transmitting a signal to the 
apparatus that controls the expression of genes involved in competence development 
and cellular differentiation (Roggiani et al., 1990; Dubnau 1991; Nakano et al., 
1991). Repression of srfA operon in the presence of excess  glucose  and  glutamine  
in  the medium  cues that   its    transcription  is  under  nutritional   regulation  
mechanism that  requires CodY (Nakano and Zuber, 1989; Nakano et al., 1991). 
DegS and DegU are also sensor and effector proteins that form a two-component 
signal transduction regulatory system, transcribed from sacU locus (Stock et al., 
1989) and  they  are  involved in the  production  of  many  types  of commercially 
valuable degradative enzymes such as extracellular proteases, α-amylase, proteases, 
intracellular serine protease and levansucrase, etc. (Tanaka et al., 1991). 
DegS protein kinase also acts as a DegU phosphatase. DegU response regulator has 
two activities according to phosphorylation state; phosphorylated form which is 
necessary for degradative enzyme synthesis and nonphoshorylated form required for 
expression of genetic competence (Dahl et al., 1992). 
DNA-dependent RNA polymerase has central importance in bacterial gene 
expression of diverse regulatory mechanisms. This effect is supplied with the 
association of core RNA polymerase with alternative sigma (σ) factors which allow 
polymerase holoenzyme for recognition of different promoter and this alternativity 
regulates the pattern of gene expression in response to environmental, cell cycle, and 
morphological signals (Helmann and Chamberlin, 1988).  
As an alternative subunit, Sigma-B (σB) responds through a complex, multibranched 
signal transduction pathway. Sigma-B control the transcription of operons which are 
responsible for diverse functions and a particular set of environmental conditions are 
required for its exppression such as, excessive heat, ethanol, salt, or acid (Price et al., 
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2002). Alternative transcription factor Sigma-B of Bacillus subtilis controls a 
stationary-phase regulon induced under growth conditions that do not favor  
sporulation. 
In addition to mentioned global regulatory genes, very recently, a novel gene, yvfI, is 
reported as required to bacilysin biosynthesis, which was identified by transposon 
mutagenesis method employed for disruption of potential bacilysin-related genes and 
screening loss of antibiotic activity against Staphylococcus aureus (Köroğlu et al., 
2008). yvfI is identified as encoding an unknown protein belonging to GntR 
familytranscriptional regulators, typically respond to metabolite effector molecules, 
consisted of conserved N-terminal domain that is involved in the DNA binding and 
C-terminal domain involved in the effector binding and/or oligomerization (Vindal et 
al., 2007; Hoskisson et al., 2006; Marchler-Bauer et al., 2005).  The  diverge  small 
molecules are triggered by these proteins and very distinct set of regulons are  
regulated (Marchler-Bauer et al., 2005). 
1.4. The Aim of The Present Study 
The direct relation of yvfI expression with bacilysin biosynthesis raised the 
possibility that yvfI expression might be under the control of global regulatory 
circuits related with the competence development, sporulation and antibiotic 
production in  B. subtilis. Therefore, the aim of the present study was focused on the 
identification of the effects of global regulatory genes srfA, oppA, comA, phrC, phrF, 
phrK, comQ (comX), comP, spo0H, spo0A, abrB, codY, degU and sigB on the 
expression of yvfI gene in B. subtilis. 
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2. MATERIALS AND METHODS 
2.1. Materials 
2.1.1 Bacterial Strains and Plasmids 
B. subtilis PY79, a prototrophic derivative of standart strain B. subtilis 168, was used 
as wild type throughout this study. The strains and their genotypes that were used in 
the study are listed in Table 2.1.  E. coli Top10F’ [lacIq TN10 (Tetr)}, mcrA ∆ (mrr 
hsdRMS-mrcBC), f80lacZ∆M15 ∆lacX74, deoR, recA1, araD139 ∆(ara-leu)7697, 
galU, galK, rsL,(strr), endA1, nupG) was used as a host for cloning of B. subtilis 
chromosomal DNA.  
2.1.2. Culture Media 
Composition and preparation of culture media are given in the Appendix A. 
2.1.3. Buffers and Solutions 
Composition and preparation of buffers ans solutions are given in the Appendix B. 
2.1.4. Chemicals and Enzymes 
The chemicals and enzymes that were used are given in the Appendix C. 
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Table 2.1 :  Bacterial strains and their genotypes used in this study 
 
      Strain Genoty                    Genotype            Source 
Bacillus 
subtilis PY79 
Wild type BPS cured protothropic 
derivative of Bacillus subtilis 168 
P.Youngman 
TEK7 yvfI::LacZ::erm T. E. Köroğlu 
TEK9 ∆abrB::cat, yvfI::lacZ::erm T. E. Köroğlu 
TEK10 ∆oppA::spc, yvfI::lacZ::erm T. E. Köroğlu 
TEK11 ∆spo0Η::cat, yvfI::lacZ::erm T. E. Köroğlu 
TEK12 ∆spo0Α::cat, yvfI::lacZ::erm T. E. Köroğlu 
KE10 ∆srfA::erm  K. Appelman 
JMS315  trpC2 pheA1 ∆comQ::spc A. D. Grossman 
BD1658 ∆comP::spc D. Dubnau 
JRL192 ∆comA::cat  A. D. Grossman 
BAL373 trpC2 pheA1 ∆abrB::cat  A. D. Grossman 
TMH307 trpC2 unkU::spc ∆codY  A. D. Grossman 
CAL7 ∆phrK7::spc  A. D. Grossman 
JMA163 ∆phrF163::cat  A. D. Grossman 
JMS751 ∆phrC::erm  A. D. Grossman 
CU741 ∆degu::kan A. D. Grossman 
ML6  ∆ML6::cm (sigma B) A. D. Grossman 
ECU1 yvfI::lacZ::erm ∆spo0A::∆abrB::cm  This study 
ECU2 yvfI::lacZ::erm ∆codY::∆abrB::cm  This study 
ECU3 yvfI::lacZ::erm ∆comQ::cm  This study 
ECU4 yvfI::lacZ::erm ∆comP::spc  This study 
ECU5 yvfI::lacZ::erm ∆phrK::spc         This study 
ECU6 yvfI::lacZ::erm ∆phrF163::cm  This study 
ECU7 yvfI::lacZ::erm ∆ML6::cm (sigmaB)     This study 
ECU8 yvfI::lacZ::erm ∆deg U::kan  This study 
ECU11 yvfI::lacZ::erm ∆comA::cm  This study 
ECU12 yvfI::lacZ::erm ∆phrC::erm  This study 
ECU13 yvfI::lacZ::erm ∆srfA::erm  This study 
ECU14 yvfI::lacZ::erm ∆codY::spc  This study 
E. coli Top10F’ lacIq TN10 (Tetr)}, mcrA ∆ (mrr-
hsdRMS-mrcBC), f80lacZ∆M15 
∆lacX74, deoR, recA1, araD139 
∆(ara-leu)7697, galU, galK, 
rsL,(strr), endA1, nupG 
M.A. Marahiel 
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2.1.5. Maintenance of Bacterial Strains 
B. subtilis strains were grown in Luria-Bertani (LB) liquid medium and kept on 
Luria-Bertani (LB) agar plates at cool (+4 ○C). E. coli strains were kept on Luria- 
Bertani (LB) agar plates (+4 ○C). All cultures were subcultured monthly. 10 % LB 
glycerol stock was prepared for each strain and kept at -80°C. 
2.1.6. pDrive Cloning Vector 
pDrive cloning vector is supplied by a QIAGEN in a linear form with a 3’ and 5’ U 
overhangs, also carrying amp and kan resistance genes and it is constructed to be 
used for direct-cloning of PCR products that were generated by non-proofreading 
DNA polymerases just like Taq Polymerase. Additionally, blue-white colony 
screening is possible while using this vector for cloning purposes. pDrive also 
contains several unique restriction endonuclease recognition sites around the cloning 
site that allows easy restriction analysis of recombinant plasmids. T7 and SP6 
promoters on either sides of the cloning site are important in order to carry out 
transcription of cloned PCR products, as well as sequence analysis. 
(http://www1.qiagen.com/HB/CRCloning).    
                                       
Figure 2.1 :  Genomic map of pDrive Cloning Vector including the functional genes 
in the structure as well as the restriction map 
(www1.qiagen.com/literature/pDrive/pcr_cloning21.pdf). 
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2.1.7. pMUTIN T3 Cloning Vector 
pMutin T3 is used for insertional gene inactivation in B. subtilis in order to 
characterize unknown open reading frames and to observe transcripional changes of 
constructed strains. This vector is a 8834 bp long plasmid and carries a reporter lacZ 
gene allowing to measure gene expression through β-galactosidase enzyme activity. 
Also pMUTIN T3 plasmid has an inducible promoter, Pspac, which can be induced 
by IPTG while normally suppressed by product of lacI gene. Besides, the plasmid 
carries amp and erm resistance genes expressed in E.coli and B. subtilis, respectively.  
             
Figure 2.2 :    Genomic map of pMUTIN T3 vector showing the restriction map and  
the functional genes (Vagner et al., 1998). 
 
2.1.8. pDR66 Cloning Vector 
pDR66 including cm resistance gene is used for co-transformation of B. subtilis cell 
during transformation period to make easy selection of  transformants which have 
same antibiotic resistance gene with competent cell. 
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Figure 2.3 :    Shematic presentation of 9,3 kb pDR66 vector used for transformation 
due to CmR  (CatR) region facilitating the selection of mutant strains 
(Ireton et al., 1993).  
 
2.2. Methods 
2.2.1. DNA Techniques and Manipulation 
2.2.1.1. Plasmid DNA Isolation 
Qiagen Plasmid Purification Mini and Midi Kits (Qiagen Inc., Valencia, CA) were 
mostly used for isolation of E. coli plasmid DNA as specified by the manufacturers.  
Bacterial cells were harvested by centrifugation at 13.000 rpm for 5 minutes. After 
removing supernatant, the pellet was resuspended in 300 µl P1 buffer (Appendix B). 
The pellet an buffer mixed complately by vortexing. Following step, 300 µl P2  
(Appendix B) buffer was added and solution mix was then incubated at room 
temperature  for 5 minutes. After incubation, 300 µl P3 (Appendix B) buffer was 
added and mixed through inverting the tubes until the lysate is no longer viscous.The 
sample was incubated for 15 minutes on ice. Then centrifuged at 13.000 rpm for 15 
minutes. Supernatant was transferred to a new 1.5 ml eppendorf tube and plasmid  
DNA was precipitated following the addition of 0,7 volume isopropanol and   
collected by centrifugation at 13.000 rpm for 30 minutes. Therefore obtained pellet 
was washed with 1 ml of 70% ethanol. Ethanol was dried out of 37 ◦C for 15 minutes 
after removing the supernatant. Lastly, the pellet was dissolved in 15 µl elution 
buffer (EB) at 37◦C and 200 rpm, and stored at -20◦C. The isolated DNA was run on 
0,8 % agarose gel. 
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2.2.1.2. Chromosomal DNA Isolation 
Chromosomal DNA of B. subtilis strains was isolated and purified by using a 
standart procedure devised for Bacillus species (Cutting and Horn, 1990).  
Overnight culture (1.5 ml) was harvested by centrifugation at 13000 rpm for 5 
minutes. After discarding the supernatant obtained the pellet was resuspended in   
567 µl of TE buffer (Appendix B) by repeated vortexing. Ten µl of proteinase K (20 
mg/ml), 6 µl of RNase (10 mg/ml), 24 µl of lysozyme (100 mg/ml) and 30 µl of 10% 
SDS were added one by one and the solution mix was incubated for 1 hour at 37°C 
in a water bath or in a termomixer. In the following step, 100 µl of 5M NaCl solution 
was added and the sample was mixed by inverting the tubes without vortexing until 
the mucosal white substance can be seen. After then, 80 µL of CTAB/NaCl  
(Appendix B). The solution was added into the mixture and it was incubated for 10 
minutes in 65°C water bath or termomixer. Freshly prepared 
phenol/chloroform/isoamyl alcohol (25:24:1) was then added to the mixture with the 
same volume of solution for extraction and it was centrifuged at 13000 rpm for 10 
minutes. In the last step of isolation,  the upper phase was transferred to a new 1.5 ml 
microfuge tube and 0.7 volume isopropanol was added. After up-down for 5-6 times, 
the sample was centrifuged at 13000 rpm for 15 minutes. The supernatant was 
removed and the pellet was washed with 1 ml 70% ethanol and centrifuged at 13000 
rpm for 5 minutes. Subsequently, the pellet was dried at 37°C for 1 hour and 
dissolved in 10 µl of TE buffer. Obtained chromosomal DNA was stored at 4°C. 
Finally, the isolated DNA was made run on 0.6% agarose gel. 
2.2.1.3. Polymerase Chain Reaction (PCR) 
The oligonucleotide primers were purchased from OPERON, Co. (Table 2.2). PCR 
was performed using Taq polymerase 10x reaction buffer from Roche. All cycles 
lasted for 1 minute. The denaturation temperature was 94oC and the extention 
temperature was 72oC. The annealing temperature for the first 5 cycles was 55oC and 
60oC for the next 25 cycles. The concentration of chromosomal DNA was 0.01 to 
0.001 ng/µl. The oligonucleotide primers were used at 1 - 10 pM (equimolar) and 
deoxyribonucleoside 5’triphosphates (dNTPs) were used at a final concentration of 2 
mM.  
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Also the other oligonucleotide primers given in Table 2.2 used for confirmation of 
deletions. 
Table 2.2 : Sequences of oligonucleotide primers (OPERON, Co.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.3 : List of  materials used for preparation of PCR mixture (www.roche- 
applied-science.com/pack-insert/4738250a.pdf). 
Primer 
 
Oligunucleotide Sequence 
yvfI HindIII Forward 5’-GCC AAG CTT ATG AAA CAG GGA GAA GGC-3’ 
 
yvfI BamHI Reverse 
 
5’-GCG GAT CCG AAT ATC CCG AAA GCA CAT-3’ 
srfA Forward 5’-TAT TTG TAC AGG GTC CGC CG-3’ 
 
srfA  Reverse 5’-AAG CAG CTT CTC TTT CTC CGC-3’ 
 
phrC PstI Forward 
 
5’-GCC CTG CAG GCG GTC TCC ACA TTT GAA AGC-3’ 
phrC BamHI Reverse 5’-CGG GGA TCC TAG  AAA  GTA GGA AGC AGA CAG-
3’ 
codY NcoI Forward 5’-CGG CCA TGG GTA TGG CTT TAT TAC AA-3’ 
 
codY BamHI Reverse 
 
 
5’-GCC GGA TTC ATG AGA TTT TAG ATT TT-3’ 
     Content of PCR Mixture Amount 
Forward primer  1 µl 
Reverse primer 1 µl 
10x Buffer (- MgCl2) 5 µl 
MgCl2 5 µl 
dNTP Mix ( 10 mM) 1 µl 
Template DNA  1 µl 
Taq polymerase 0,5 µl 
dH2O 35,5 µl 
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A master mix composed of the materials listed below (Table 2.3) was prepared. 
Then, the master mix was divided into separate PCR tubes and 1 µl of chromosomal 
DNA of Bacillus subtilis PY79 was added into each tube as template DNA. Finally, 
0.5 µl of Taq polymerase was added separately. 
2.2.1.4. Agarose Gel Electrophoresis  
According to basis of the purpose of electrophoresis, different concentration of 
agarose gels were used, which were given in Table 2.4. Electrophoresis was carried 
out on a horizontal submarine electrophoresis apparatus and in a neutral gel system 
composed of  1%  agarose gel containing 1xTAE buffer (Appendix B) and ethidium 
bromide of a 0.2 µg/mL final concentration. Loading dye (6X) was added into the 
samples. Electrophoresis was performed at 90-120 Volts for 20-30 minutes. The 
DNA bands were visualized on a shortwave UV transilluminator (UVP) and 
photographed by using Gel Imaging System. EcoR1 digested lambda DNA marker 
(Appendix D) was used to determine the molecular weights of DNA bands. 
 
Table 2.4 : Agarose gel concentration for different samples 
 
 
 
 
 
 
 
2.2.1.5. Gel Extraction 
The desired fragments were extracted from the gel by using a Qiaquick Gel 
Extraction kit (Qiagen Inc., Valencia, CA). The gel slice containing the DNA band  
was excised from the gel and DNA extraction from gel was performed according to 
the Qiagen’s instructions. After obtaining DNA, an aliquot was run on agarose gel to 
monitore the DNA concentration. 
 
 
                 Sample Concentration 
Chromosomal DNA 0,6 % 
Plasmid DNA 0,8 % 
Digestion products of 
plasmid 
1 % 
PCR products   1.5 % - 2 % 
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2.2.1.6. Ligation of PCR Products into pDrive Cloning Vector 
Ligation of PCR products to pDrive Vector was performed as follows: Ligation 
master mix buffer (5 µl), 1 µl (50 ng/µl) pDrive vector, 2 µl insert DNA (PCR 
product) and 2 µl dH2O was added and total volume was completed to 10 µl. 
Reaction mixture was incubated at 16◦C for 1.5 hours then ligase was denaturated at 
70◦C for 10 minutes. After ligation was completed, the mixture was used for 
transformation into E.coli Top10F’.    
2.2.1.7. Ligation of pMutinT3 Vector 
Ligation procedure for cloning into the pMutinT3 vector was carried out using 9.5 µl 
of yvfI PCR products as insert fragments and 0.5 µl of pMutinT3 vector. Vector and 
fragment were mixed in an eppendorf tube and incubated for 5 min at 65°C. Then, 
the tube was cooled on ice. Following cooling step, 2 µl of ligation 10x buffer, 2 µl 
of Polyethylene glycol (50% PEG 8000), 2 µl of T4 DNA ligase, 4 µl of dH2O were 
added into the same eppendorf tube. Finally, the mixture was again centrifuged for a 
short spin and incubated at 4°C for 16 h. 
2.2.1.8. Restriction Enzyme Digestion 
Digestion reactions were carried out as the constructerer's manufacture, in a way that 
the amount of 10X digestion buffer was 1/10 of the total reaction mix. The reaction 
mix was incubated for 1-4 hours at 37°C, then enzyme denaturation at 65°C for 10 
minutes. The sample was stored at -20oC when was needed. 
2.2.2. Transformation 
2.2.2.1. Preparation of E.coli Electrocompetent Cells and Transformation of 
Electrocompetent E.coli Top10F’ Cells 
The overnight inoculum of E.coli Top10F’ was diluted 1:100 fold into 400 ml 2xYT 
medium which was contain Tetracyclin (20 µg/ml). Then  incubated at 37 oC with 250 
rpm by shaking until OD600 (Optical Density at 600 nm) reached to 0,6. Then 
incubated cells were stayed on ice for 30 minutes and after cold incubation period 
cells were harvested by centrifugation at 5000 rpm for 5 minutes. Subsequent to  
discard supernatant, tha pellet was resuspended in 40 ml of cold distilled water and 
centrifuged at 5000 rpm for 15 minutes. Supernatant  was  removed and  pellet  was 
resuspended in 20 ml cold distilled water and centrifuged at 5000 rpm for 15 minutes 
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again. Lastly, supernatant was discarded and pellet was resuspended in 1 ml of cold 
steril 10 % glycerol. After then, it was dispensed into aliquots of 40 µl into eppendorf 
tubes. Aliquots were frozen immediately by immersing within liquid nitrogen and 
stored at -80 oC. 
For transformation, competent E. coli cells were incubated on ice shortly. Ligation 
products (10 µl) or 0.5 µg of appropriate plasmid DNA was added into the tube of 
competent cell and were mixed by hand gently. Then, mix was transferred into pre-
cold electroporation tube. The sample was placed onto electroporation device and the 
process was carried out at 1800V. After addition of 1ml LB broth into the mixture, it 
was transferred into a 2 ml eppendorf tube. Incubation was made at 37oC for 60 
minutes by shaking at 200 rpm. After incubation, the cells were centrifuged at 5000 
rpm for 10 min and supernatant was discarded. Obtained pellet was resuspended in 
100 µl 85 % saline solution (NaCl)(Apendix B). Transformed cells were plated on 
selective medium containing appropriate antibiotic (100µg/ml ampicillin). For the 
purpose of blue-white colony selection, they were plated on LB agar media 
containing 40 mg/ml X-gal, 1 mM IPTG and 100µg/mL ampicillin. 
2.2.2.2. Preparation of B. subtilis Competent Cells and Transformation 
Preparation of B. subtilis competent cells and transformation were performed as 
described by Klein et al. (1992). HS and LS (Appendix B) mediums were used for 
the preparation of B. subtilis competent cells. Appropriate amount of B. subtilis cells 
were inoculated into 3 ml of HS medium and it was cultured  overnight at 37°C by 
shaking at 250 rpm. 0,5 ml of this overnight inoculum was transformed into 20 ml of 
freshly prepared LS medium and incubated at 30°C by shaking at 200 rpm until 
OD600  reached to 0,55. Then, 1 ml of competent cells was transferred into 2 ml 
eppendorf tube inwhich contained 1 µl of chromosomal DNA or suitable plasmid 
was added. The cells were then incubated at 37°C for 2 hours by shaking at 200 rpm 
and incubated cells were harvested by centrifugation at 5000 rpm for 10 minutes. 
Lastly, the pellet was resuspended in 100 µl of sterile saline solution and was spread 
out on LB agar plates containing selective antibiotic and incubated at 37°C for 16 h. 
2.2.2.3. Induction of MLS Gene 
Competent B. subtilis cells were  incubated in HS medium  until OD600 reached  to 
0,55 by the same conditions given the Section 2.2.2.2 and then incubated for 2 hours. 
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In the overlay step, firstly, 2 µl of 2 mg/ml erythromycin antibiotic solution was 
added into a small test tube containing 2,5 ml % 0.7 LB agar which was melted and 
kept in 50°C. Then, immediately, all amount of transformed cells were added into 
same tube, mixed quickly and were poured onto an antibiotic-free LB agar plate 
containing 25 ml LB agar. Following incubation at 37°C for 2 hours, a second 
overlay was performed. This second overlay has contained 2.5 ml of melted % 0.7 
LB agar, 20 µl (2 mg/ml) erythromycin antibiotic solution and 20 µl (50 mg/ml) 
lincomycin antibiotic solution. The agar plate was incubated at 37°C for 1-2 days. 
2.3. Beta-Galactosidase Activity Assay 
Initially, all strains were grown overnight at 37°C in PA medium (Appendix A). 
Then, they were used to inoculate 100 ml of PA medium to an initial optical density 
of about 0,1 at 595 nm (OD595). The cultures were incubated at 37°C shaking at 250 
rpm for 30 h. 1 ml of culture was collected as double eppendorf tubes for each hour 
for checking up of assay. If it was needed, suitable dilution was made for 
measurement.  
After each sampling, the culture was centrifuged at 13000 rpm for 5 minutes and the 
supernatant was discarded. Then, the pellet was washed with 500 µl of ice-cold 25 
mM Tris-Cl (pH 7.4) by centrifugation. Following, the removal of the supernatant, 
the pellet was resuspended in 650 µl Z-buffer by vortex and 170 µl of lysozyme was 
added. Later, the solution was vortexed for a second and incubated at 37°C for 5 min. 
Subsequently, the samples were taken on ice and 9 µl of 10% Triton-X 100 was 
added. After vortexing for a while, the extracts were incubated  at  30°C for 5 min. 
Subsequent to this, 200 µl of ONPG solution was added, incubated at 30°C and the 
solution was watched for the progression of the yellow color. Following, the reaction 
was stopped by the addition of 1 M Na2CO3 and reaction time was recorded. 
Reaction time refers to a period that was started by adding ONPG and continued 
until formation of the yellow color, and so this period was recorded. At last, the 
samples were centrifuged at 13000 rpm for 5 min. and the supernatant was taken to 
measure A420 and A550 sepearately. Calculations for β-galactosidase activity were 
carried out according  to  the  formulation (Miller, 1972)  below  and a  graph for  
both  the  β galactosidase activity and log OD595 was drawn seperately. 
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                                  A420 – (1.75 x A550 )  
Miller units =   --------------------------------------   x 1000                                        
                              Reaction time (min) x OD595                                                      (2.1)                                                                                           
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3.  RESULTS AND DISCUSSION 
3.1. Construction of yvfI Insertional Plasmid 
To achieve integration of pMUTIN T3 vector, firstly, a yvfI gene fragment, 508 bp in 
lenght, was amplified using chromosomal DNA of Bacillus subtilis PY79 wild type 
strain as a template by PCR. The primers yvfI Forward 5’ 
GCCAAGCTTATGAAACAGGGAGAAGGC 3’ and yvfI Reverse 5’ 
GCGGATCCGAATATCCCGAAAGCACAT 3’ including extra residues for BamHI 
and HindIII recognition sites were used for the amplification of yvfI gene fragment. 
Hence, a total of 525 bp PCR product was obtained by PCR (Fig. 3.1). 
The amplified PCR product was purified after running in agarose gel. Extracted 
fragment was ligated into pDrive Cloning Vector (Qiagen) and transformed into E. 
coli Top10F’ electro-competent cells. Suitable plasmid carrying 525 bp insert within 
pDrive vector was selected and the sequence analysis was performed. The deduced 
nucleotide sequence data was compared to B. subtilis genome sequence, using Blast 
search, at National Center for Biotechnology Information (NCBI) database. 
                  
 
 
 
 
 
Figure 3.1 :  1-2; PCR products of 525 bp yvfI gene fragment  amplified with spesific 
primers yvfI F and yvfI R and M; Marker 3: Lambda DNA / 
EcoRI+HindIII (Appendix D).  
21226 bp 
3530 bp 
2027 bp 
947 bp 
564 bp 
5148 bp 
1375 bp 
 M      1        2 
525 bp yvfI fragments 
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This recombinant pDrive and pMUTIN T3 vectors were digested with the same 
restriction enzymes, BamHI and HindIII,  and were run in agarose gel. Following 
that yvfI fragment from pDrive and digested pMUTIN T3 were extracted from gel 
and these were ligated overnight with T4 ligase. Transformation of ligation product 
into E. coli Top10F’ competent cells was carried out. Transformants were selected 
on 100 µg/ml  ampicillin containing agar plates. Plasmid DNAs were isolated from 
the selected colonies, which were expected to carry the recombinant pMUTIN T3 
plasmid,  and run on agarose gel in order to verify the expected size (9359 bp). Then,  
one of the suitable sized plasmids was selected and digested with BamHI and HindIII 
restriction enzymes for confirmation of existing of yvfI fragment in the pMUTIN T3 
vector (Figure 3.2A). 
In order to verify the existence of yvfI fragment and also erm casette, the selected 
recombinant plasmid was used as template in the PCR with specific primers and  
expected bands were obtained on agarose gel as can be seen in the Figure 3.2B.  
 
Figure 3.2 :  The confirmation of yvfI gene cloning into pMutinT3 vector. A: HindIII 
ve BamHI double digestion of recombinant plasmid (1), B: PCR 
products for  yvfI gene (1) and  erm casette (2) amplified using DNA of 
recombinant plasmid as template, M: Marker 3: Lambda DNA / 
EcoRI+HindIII.  
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 3.2. Construction of yvfI::lacZ Transcriptional Fusion in B. subtilis  
The selected recombinant pMUTIN T3 plasmid carrying 525 bp yvfI fragment was 
transformed into B. subtilis PY79 wild type strain in order to construct 
yvfI::lacZ::erm transcriptional fusion in its chromosome. The integration was as a 
result of a single cross-over event at yvfI locus, in the other name Campbell-like 
insertion.  
The selection according to erythromycin resistance on LB plates containing 
erythromycin (1µg/mL) could not be fully performed because of the generation of the 
spontaneous erythromycin resistant B. subtilis PY79 cells. In order to eliminate this 
problem, an alternative selection method, Macrolide-Lincosamide-Streptogramin B-
resistance (MLSR) conferred by erm gene, was used. Chromosomal DNA of the 
resultant MLSR transformant was isolated and screened with PCR analysis by using 
primers specific to erm resistance gene on pMUTIN T3 in order to confirm the 
insertion of the plasmid into the B. subtilis chromosome. 703 bp erm gene was 
amplified by using the chromosomal DNA of MLSR B. subtilis transformant as 
template (Fig 3.3). The corresponding MLSR  B. subtilis PY79 transformant was 
designated as TEK7. 
                           
Figure 3.3 :  The confirmation of yvfI::lacZ::erm in B. subtilis chromosome. 1: PCR 
product amplified with specific primers to erm resistance gene within 
pMutinT3 vector using chromosomal DNA of yvfI::lacZ::erm mutant 
as template; 2: PCR product amplified with specific primers to yvfI 
gene using chromosomal DNA of yvfI::lacZ::erm mutant as template; 
M: Marker 3: Lambda DNA / EcoRI+HindIII. 
 
703 bp erm       
casette 
21226 bp 
 3530 bp 
2027 bp 
   947 bp 
 5148 bp 
     M                   1        2   
 29
3.3. Expression of Transcriptional yvfI::lacZ Fusion in PA Medium 
In order to compare the expression level of yvfI both in yvfI::lacZ mutant strain 
TEK7 and wild type B. subtilis PY79, as control, cells were grown in PA medium, 
which is a defined medium stimulating bacilysin production, at 37◦ C with 200 rpm 
and  samples were collected at every hour till the end of thirty hours, and also growth 
of cells was monitored. Collected cells was assayed for β-galactosidase assay, using 
ONPG as substrate, enzyme activity was calculated. The results of expression of 
yvfI::lacZ fusion and B. subtilis PY79 wild type strain  were compared as can be seen 
in the Figure 3.4. As growth of both strains were similar, expression of yvfI in TEK7 
mutant strain was  increased in the exponential phase slowly, then was increased in 
the transition state between exponential and stationary phase steadily and reached to 
its maximal level (detected as 62 Miller units) upon entry into stationary phase (Fig. 
3.4).                                         
 
Figure 3.4 :  Growth and bacilysin activity of B. subtilis PY79 and TEK7 
(yvfI::lacZ::erm) strains grown in PA medium. Specific Miller Units 
was calculated with formula as denoted in  Section 2.3 (2.1). The 
symbols used for the strains are; (○) PY79 (wild type) and (●) TEK7 
(yvfI::lacZ::erm). 
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3.4. Deletion of regulatory Genes and Their Effects on the Expression of yvfI 
gene in B. subtilis 
3.4.1. Deletion of srfA Gene and Its Effect on the Expression of yvfI Gene in  
Bacillus subtilis 
srfA operon is consisted of four modular open reading frames (ORFs); ORF1 (srfA-
A),ORF2 (srfA-B), ORF3 (srfA-C) and ORF4 (srfA-D).  It is an important operon 
needed for the efficient development of genetic competence which is regulated by 
ComA response regulatory protein. The operon is normally expressed during active 
growth at a low level, just before the transition to stationary phase, its transcription is 
increased sharply dependent on comA, spo0K  and comQ activity (Van Sinderen et 
al., 1990, Weinrauch et al., 1991; Cosby et al., 1998). Null mutations of those three 
genes resulted with decreased expression level of srf.  Therefore, it seems as srf 
operon might be an intermediate component of the regulatory pathway (Hahn and 
Dubnau, 1991).  
To monitore the effect of srfA knockout profile, srfA gene was disrupted in the 
transcriptional yvfI::lacZ fusion strain TEK7. For this purpose, ∆srfA::erm comS+ 
mutant derivative of B. subtilis was used as competent cell, then was co-transformed 
with chromosomal DNA of TEK7 and pDR66 plasmid (used to facilitate selection on 
agar plates via cm antibiotic casette region. Transformants were selected with 
resistance to Erm(1µg/ml), Ln (25µg/ml) and Cm (20 µg/ml) antibiotics and then 
were screened with PCR using specific primers (Table 2.2). Lastly selected mutant 
was named as ECU13 (yvfI::lacZ::erm ∆srfA::erm).   
The resulting strain ECU13 and TEK7, as control strain, were cultured in PA 
medium and were sampled in 1 h intervals for the β-galactosidase assay. Growth 
curves and β-galactosidase activities were shown in Figure 3.5 and in the Figure  3.6, 
respectively. 
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Figure 3.5 :  Growth curves of mutant strains grown in PA medium. The symbols 
used for the strains are; (□) TEK7 (yvfI::lacZ::erm) and  (▲) ECU13 
(yvfI::lacZ::erm ∆srfA::erm). 
 
 
       
Figure 3.6 :  β-Galactosidase activities of mutant strains grown in PA medium and 
their effects on yvfI-lacZ expression. Specific Miller Units was 
calculated with formula as denoted in Section 2.3. The symbols used 
for the strains are; (■) TEK7 (yvfI::lacZ::erm) and (▲) ECU13 
(yvfI::lacZ::erm ∆srfA::erm). 
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As shown in Fig. 3.6, in the absence of srfA gene product, yvfI gene expression was 
completely disrupted. Nakano et al. (1991) revealed that 5' half of the srfA operon 
was essential for surfaction formation, sporulation and genetic competence, but  3' 
half of srfA operon was not required for genetic competence. So it was predicted that 
srfA gene products act in B. subtilis cell specialization and differentiation. In 2003, it 
was shown that srfA disrupted mutants were not able to produce bacilysin, hence srfA 
might be effective on bacilysin biosynthesis (Yazgan-Karataş et al., 2003). In the 
present  study, it was found that, srfA was also directly effective on yvfI expression 
as bacilysin biosynthesis.  
3.4.2. Deletion of oppA Gene and Its Effect on the Expression of yvfI gene B. 
subtilis 
The spo0K (opp) is an operon encoding oligopeptide permease, ATP-binding casette 
transporter. Five proteins OppA, OppB, OppC, OppD, and OppF which are products 
of this operon, are required for uptake of oligopeptides, development of genetic 
competence, and initiation of sporulation in Bacillus subtilis (LeDeaux et al., 2006). 
Exported inhibitory peptides are accumulated in the culture supernatant and then they 
are imported by the oligopeptide permease (Lazazzera et al., 1997).  Firstly OppA 
binds to oligopeptide substrate and delivers it to the rest part of the operon (Perego et 
al.,  1991). Null mutations on spo0KABCD have proven that they are required for 
mentioned cell responses, but disruption of spo0KE caused a less severe phenotype 
than disruption of other genes of the operon (LeDeaux et al., 1997).   
In order to analyze the deletion effect of oppA gene on yvfI expression, it was deleted 
in TEK7 (yvfI::lacZ::erm) by transforming the competent cells of TEK7 with the 
chromosomal DNA of the ∆oppA::Tn10(spc) mutant strain AK3. Then, selection of 
transformants on agar plate containing Spc (100µg/ml) was performed.  Selected 
mutant was named as TEK10 (yvfI::lacZ::erm ∆oppA::spc),  
The resulting strain TEK10 and TEK7, as the control, were cultured in PA medium 
and were sampled in 1 h intervals for the β-galactosidase assay. Growth profiles were 
shown in Figure 3.7 and β-galactosidase activities were shown in the Figure  3.8. 
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Figure 3.7 :  Growth curves of TEK7 (yvfI::lacZ::erm) and TEK10 (yvfI::lacZ::erm 
∆oppA::spc) strains grown in PA medium. The symbols used for the 
strains are; (■)TEK7 (yvfI::lacZ::erm) and  (▲) TEK10 
(yvfI::lacZ::erm ∆oppA::spc) 
 
    
Figure 3.8 :  β-Galactosidase activities of TEK7 and oppA-deleted mutant strain 
grown in PA medium and effect of deletion on yvfI-lacZ expression. 
The symbols used for the strains are; (♦) TEK7 (yvfI::lacZ::erm) and 
(▲) TEK10 (yvfI::lacZ::erm ∆oppA::spc). 
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Fig. 3.8 shows that yvfI-lacZ expression was severely disrupted in absence of oppA 
gene product both during exponential and stationary phases. It should be noted that 
distruption of oppA was resulted in the same effect on the biosynthesis of bacilysin. 
As being a key component of QS, oppA mutation creates a loss of  bacilysin 
biosynthesis, it was suggested that bacilysin biosynthesis is under the global quorum 
sensing mechanism or a component of this mechanism. (Yazgan et al., 2001). So, we 
can propose that yvfI expression can be regulated crucially with oppA, as a part of 
quorum sensing mechanism. 
A family of phosphatases (Rap) and cognate regulators (Phr) modulate the two-
component signal transduction systems in Bacillus subtilis.  Phosphatases are 
encoded together with their negative regulators, pentapeptides in the other name 
pheromone peptides. This operon system also includes a binding site for alternative 
subunit of RNA polymerase (Perego et al., 1994; Perego and Hoch, 1996).  
The effects of deletion mutations on phrC, phrF, and phrK was studied by Achtung 
et al. (2006), and it was indicated that those peptides stimulate ComA-dependent 
gene expression within different level and in the absence of all three peptides the 
ComA-dependent genes could not be fully expressed and the involvement of ComA 
and PhrC in bacilysin biosynthesis was shown (Yazgan et al., 2001). Therefore Opp-
imported other pheromones PhrF and PhrK as well as PhrC are  considered to have 
function in yvfI expression and thus the expression of yvfI-lacZ expression was 
examined in the PhrC,PhrF and PhrK mutant backgrounds, as shown in the following 
sections. 
3.4.3. Deletion of Phr Peptides Genes (phrC, phrK, phrF) and Their Effects on 
the Expression of  yvfI gene  in B. subtilis 
In order to examine the effects of blockage of phrC,  phrK, and  phrF genes on  
yvfI::lacZ fusion mutant strain TEK7,  ECU5 (yvfI::lacZ::erm ∆phrK::spc), ECU6 
(yvfI::lacZ::erm ∆phrF163::cm)   mutant strains were constructed seperately via 
transformation of TEK7 mutant strain with JMS751 (∆phrC::erm), CAL7 
(∆phrK7::spc) and JMA163 (∆phrF163::cat) chromosomal DNAs, respectively. For 
deletion of phrC gene in TEK7 (yvfI::lacZ::erm), the competent cells of ∆phrC::erm 
PY79, supplied by Grossman, was co-transformed with chromosomal DNA of TEK7 
and pDR66 plasmid and selection was made depending on the resistance to 
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Erm(1µg/ml), Ln (25µg/ml) and Cm (20 µg/ml) antibiotics. One of transformants was 
selected and named as ECU12 (yvfI::lacZ::erm ∆phrC::erm). Also deletion 
mutations were confirmed by PCR analysis using specific primers (Table 2.2). 
Resulting strains were named as ECU5 (yvfI::lacZ::erm ∆phrK::spc) and  ECU6 
(yvfI::lacZ::erm ∆phrF163::cm)   mutant strains were constructed in the sanme 
prosedure.  
The resulting strains ECU12, ECU5, ECU6 and TEK7 were cultured in PA medium 
and the specific activities of the samples were measured. Also growth of mutants was 
followed (Fig. 3.9, 3.10, 3.11, 3.12). 
                                                                                                       
 
Figure 3.9 : Growth curves of TEK7 (yvfI::lacZ::erm), ECU5 (yvfI::lacZ::erm 
∆phrK::spc), ECU6 (yvfI::lacZ::erm ∆phrF163::cm)  and  ECU12 
(yvfI::lacZ::erm ∆phrC::erm) strains grown in PA medium. The 
symbols used for the strains are; (∆) TEK7 (yvfI::lacZ::erm), (♦) 
ECU5 (yvfI::lacZ::erm ∆phrK::spc), (●) ECU6 (yvfI::lacZ::erm 
∆phrF163::cm)  and  (■) ECU12 (yvfI::lacZ::erm ∆phrC::erm). 
  
Deletion results of phrC, phrK and phrF163 genes are shown in the following figures 
(Fig. 3.10, Fig. 3.11 and Fig 3.12).  
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Figure 3.10 :  β-Galactosidase activities of TEK7 and phrC-deleted mutant strain 
grown in PA medium and effect of deletion on yvfI-lacZ expression. 
The symbols used for the strains are; (♦) TEK7 (yvfI::lacZ::erm) and 
(■) ECU12 (yvfI::lacZ::erm ∆phrC::erm). 
 
           
Figure 3.11 :  β-Galactosidase activities of TEK7 and phrK-deleted mutant strain  
grown in PA medium and effect of deletion on yvfI-lacZ expression. 
The symbols used for the strains are; (♦) TEK7 (yvfI::lacZ::erm) and 
(■) ECU5 (yvfI::lacZ::erm ∆phrK::spc).   
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Figure 3.12 :  β-Galactosidase activities of TEK7 and phrF163-deleted mutant strain  
grown in PA medium and effect of deletion on yvfI-lacZ expression. 
The symbols used for the strains are; (♦) TEK7 (yvfI::lacZ::erm) and 
(■) ECU6 (yvfI::lacZ::erm ∆phrF163::cm).   
 
As shown in Fig 3.10, Fig. 3.11 and Fig. 3.12, the deletion mutation of phrC, phrF 
and phrK genes affected yvfI::lacZ expression seriously. Therefore, our results 
indicate that the Phr C, F and K peptides are required for the regulation of yvfI 
expression supposingly by enhancing the full activation of transcriptional factor 
ComA~P as in the case of bacilysin biosynthesis. 
3.4.4. Deletion of comQ(comX), comP, comA and spo0H and Their Effects on the 
Expression of yvfI gene in B. subtilis 
The comQ, comX, comP and comA genes are clustered, in this order, on the 
chromosome of B. subtilis. The upstream gene comQ is needed for producing a 
modified peptide pheromone in the system (Kleerebezem et al., 1997). 
Bacillus subtilis can use excreted peptide signals to mediate quorum sensing and to 
activate the transcription factor ComA (Lazazzera et al., 1999; Bongiorni et al., 
2005). ComA is part of a  two-component  regulatory  system and   is  activated  by  
phosphorylation via membrane-bound sensor histidine-protein kinase, ComP 
(Weinrauch et al., 1990; Core and Perego 2003).  
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ComX pheromone is an extracellular signaling peptide that activating the 
autophosphorylation of ComP and hence, activates the ComA transcriptional 
regulator in order to control expression of varied quorum-responsive genes, such as 
srfA, degQ, rapA and rapC (Magnuson et al., 1994; Solomon et al., 1995; Lazazzera 
and Grossman, 1998).  
Spo0H(σH) encoded by spo0H is an alternative subunit for RNA polymerase and  
involves in many cellular responses. It is known that the expression of the phr genes 
is controlled via sigma-H(spo0H gene product)-dependent promoter (P2) located at 
upstream of phrC and internal to rapC and most likely contribution of the effects of 
cell density on sporulation, also genetic competence, because of  such events are 
more effective at high cell density as a result of accumulated peptides (Lazazzera et 
al., 1999). Defects in production of some of signaling peptides in spo0H mutants are 
indicated that several cellular responses are modulated by population density and by 
controlling effect of Sigma-H on the expression of the phr genes by sensing 
extracellular peptides (Rudner et al., 1991; Ireton et al., 1993; Lazazzera et al., 1997; 
McQuade et al., 2001). 
comQ, comP, comA and spo0H genes were examined whether  they effect on yvfI 
expression or not. For this  purpose, comQ, comP, comA and spo0H genes were 
insertionally deleted in TEK7. TEK7 (yvfI::lacZ::erm) was used as competent cell 
and transformed  with chromosomal DNAs of corresponding null mutants. Resulting 
transformants were named as ECU11 (yvfI::lacZ::erm ∆comA::cat), ECU3 
(yvfI::lacZ::erm ∆comQ::spc), ECU4 (yvfI::lacZ::erm ∆comP::spc), and TEK11 
(yvfI::lacZ::erm ∆spo0H::cat). 
The resulting strains ECU3, ECU4, ECU11, TEK11 and TEK7 were cultured in PA 
medium and the specific β-galactosidase activities of the samples were measured 
while growth profiles of mutants was followed (Fig. 3.13, 3.14, 3.15, 3.16, 3.17). 
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Figure 3.13 : Growth curves of TEK7 (yvfI::lacZ::erm), ECU3 (yvfI::lacZ::erm 
∆comQ::spc), ECU4 (yvfI::lacZ::erm ∆comP::spc), ECU11 
(yvfI::lacZ::erm ∆comA::cat) and TEK11 (yvfI::lacZ::erm 
∆spo0H::cat) strains grown in PA medium. The symbols used for the 
strains are; (■) TEK7 (yvfI::lacZ::erm), (♦) ECU3 (yvfI::lacZ::erm 
∆comQ::spc), (▲) ECU4 (yvfI::lacZ::erm ∆comP::spc), (◊) ECU11 
(yvfI::lacZ::erm ∆comA::cat) and (○) TEK11 (yvfI::lacZ::erm 
∆spo0H::cat). 
               
Figure 3.14 :  β-Galactosidase activities of TEK7 and comA-deleted mutant strain 
grown in PA medium and effect of deletion on yvfI-lacZ expression. 
The symbols used for the strains are; (♦) TEK7 (yvfI::lacZ::erm) and 
(■) ECU11 (yvfI::lacZ::erm ∆comA::cat).        
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Results of deletion of comP, comQ and spo0H genes are given in the following 
figures (Fig. 3.15,  Fig. 3.16 and Fig. 3.17).  
             
Figure 3.15 :    β-Galactosidase activities of TEK7 and comP-deleted mutant strain 
grown in PA medium and effect of deletion on yvfI-lacZ expression.  
The symbols used for the strains are; (♦) TEK7 (yvfI::lacZ::erm) and 
(■) ECU4 (yvfI::lacZ::erm ∆comP::spc).   
           
Figure 3.16 :   β-Galactosidase activities of TEK7 and comQ-deleted mutant strain 
grown in PA medium and effect of deletion on yvfI-lacZ expression. 
The symbols used for the strains are; (♦) TEK7 (yvfI::lacZ::erm) and 
(■) ECU3 (yvfI::lacZ::erm ∆comQ::spc) 
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Figure 3.17 :   β-Galactosidase activities of TEK7 and spo0H-deleted mutant strain 
grown in PA medium and effect of deletion on yvfI-lacZ expression. 
The symbols used for the strains are; (♦) TEK7 (yvfI::lacZ::erm) and 
(■) TEK11 (yvfI::lacZ::erm ∆spo0H::cat). 
 
As shown in Fig. 3.14, Fig 3.15, Fig. 3.16 and Fig. 3.17, yvfI activity was impaired in 
the deletion of comA, comP, comQ and spo0H genes and yvfI::lacZ expression was 
repressed completely. ComQ  was put forth as required for correct processing of 
ComX pheromone, so that ComQ effects expression of srfA and transformability via 
ComX (Magnuson et al., 1994). ComP and ComX were required for signal 
transduction system that activate ComA and also σH required for phr gene expression 
during transition state initiating signal transduction cascade for ComA~P-dependent 
gene expression as quorum response. In this point, it would not be wrong to suggest 
that expression of yvfI gene was regulated in a ComA-dependent manner and 
probably, the products of these genes might regulate bacilysin biosynthesis through 
affecting the expression of yvfI gene. 
3.4.5. The Effects spo0A and abrB Null Mutations on the Expression of yvfI gene 
in B. subtilis 
Spo0A is the master regulatory protein which is effective on  the expression of over 
500 genes the early stages of stationary phase, directly or indirectly in Bacillus 
subtilis genome (Molle et al., 2003). Particularly disruption on spo0A in B. subtilis is 
resulted with blockage of  sporulation and exhibition pleiotropic effects on the 
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expression of a wide range genes associated with the transition state (Strauch et al., 
1990). 
A wide variety of antibiotics and antifungals are synthesized and secreted by Bacillus 
species upon depletion of nutrients and entry into stationary phase (Zuber et al., 
1993). In spo0A disrupted mutants of Bacillus subtilis, the synthesis of antimicrobials  
and also resistanca against other antibiotics were found to be deficient. These effects 
of spo0A mutations were associated with AbrB global regulator protein which is 
repressed by Spo0A (Trowsdale et al., 1978; Staruch et al., 1990; Strauch, 1993).It 
was indicated that the Spo0A protein binds to a specific region of the abrB gene 
located downstream from the transcriptional start sites and functions as a repressor of 
transcription in vitro (Staruch et al., 1990). 
To analyze the effects of spo0A and abrB null mutations, spo0A and abrB genes were 
inactivated in TEK7, the transcriptional yvfI::lacZ fusion strain, separately. For this 
knockout mutation, TEK7 competent cells were used for the transformation of 
chromosomal DNAs of ∆spo0A::cat mutant and ∆abrB::cat mutant derivatives. The 
selected mutants with regard to specific antibiotic resistance were named as TEK9 
(yvfI::lacZ::erm ∆abrB::cat), TEK12( yvfI::lacZ::erm ∆spo0A::spc) and ECU1( 
yvfI::lacZ::erm ∆spo0A::∆abrB::cm). Additionally the expression of yvfI::lacZ 
fusion was analyzed in  spo0A-abrB double mutant genetic background for detection 
of the effect of absence of both repressor proteins that repress different genes in 
sequential stages. spo0A-abrB double mutant strain ECU1 (yvfI::lacZ::erm 
∆spo0A::spc ∆abrB::cat) was constructed by transforming the competent cells of 
TEK9 with chromosomal DNA of the ∆abrB::cat mutant strain of B. subtilis. 
Transformants were selected on agar plates containing antibiotics Cm (5 µg/ml) and 
Spc (100µg/ml). In addition, this double mutant strain was performed on DSM 
(Appendix A) agar plate in order to detect sporulation ability. 
The resulting strains ECU1, TEK9, TEK12 and TEK7 as the control were cultured in 
PA medium and were sampled in 1 h intervals. Collected samples were further 
assayed for β-galactosidase activity (Fig. 3.19, 3.20, 3.21). At the same time growth 
profiles of mutants were analyzed (Fig. 3.18). 
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Figure 3.18 :  Growth curves of TEK7 (yvfI::lacZ::erm), TEK9 (yvfI::lacZ::erm 
∆abrB::cat), TEK12 (yvfI::lacZ::erm ∆spo0A::spc) and ECU1 
(yvfI::lacZ::erm ∆spo0A::∆abrB::cm) strains grown in PA medium. 
The symbols used for the strains are; (∆) TEK7 (yvfI::lacZ::erm), 
(▲) ECU1 (yvfI::lacZ::erm ∆spo0A::∆abrB::cm), (■) TEK9 
(yvfI::lacZ::erm ∆abrB::cat) and (◊) TEK12 (yvfI::lacZ::erm 
∆spo0A::spc). 
 
            
Figure 3.19 :  β-Galactosidase activities of TEK7 and abrB-deleted mutant strain 
grown in PA medium and effect of deletion on yvfI-lacZ expression. 
The symbols used for the strains are; (♦) TEK7 (yvfI::lacZ::erm) and 
(■) TEK9 (yvfI::lacZ::erm ∆abrB::cat). 
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Deletion results of spo0A and spo0A-abrB genes are shown in the following figures 
(Fig. 3.20 and Fig 3.21).  
        
Figure 3.20 :   β-Galactosidase activities of TEK7 and spo0A-deleted mutant strain 
grown in PA medium and effect of deletion on yvfI-lacZ expression. 
The symbols used for the strains are; (♦) TEK7 (yvfI::lacZ::erm) and 
(■) TEK12 (yvfI::lacZ::erm ∆spo0A::spc). 
          
Figure 3.21 :   β-Galactosidase activities of TEK7 and spo0A-abrB-deleted mutant 
strain grown in PA medium and effect of deletion on yvfI-lacZ 
expression. The symbols used for the strains are; (♦) TEK7 
(yvfI::lacZ::erm) and (■) ECU1 (yvfI::lacZ::erm 
∆spo0A::∆abrB::cm). 
 45
 
As seen in Fig. 3.20 the expression of yvfI::lacZ was fully eliminated by deletion of 
spo0A gene. In abrB null mutation, a relief was monitored in the expression profile 
during exponential growth, on the other hand, in stationary phase severe repression 
of yvfI::lacZ expression was observed (Fig. 3.19). Besides, it was encountered an 
unexpected result with yvfI::lacZ expression in spo0A-abrB double mutant strain 
(Fig. 3.21). It was suggested that abrogated yvfI expression could be relieved by null 
mutation in abrB in spo0A mutation background in TEK7. But in contrarily, not only 
yvfI::lacZ expression was abolished completely, but also life span was shortened due 
to double mutation in spo0A-abrB double mutant strains ECU1. In light of these data, 
it was proposed that spo0A was needed for yvfI gene expression and AbrB was 
required for the induction for maximum yvfI expression at the onset of stationary 
phase as well as Spo0A. It was also suggested that beside to abrB  there might be 
other regulator(s) interferring in yvfI::lacZ expression profile in the absence of abrB.  
3.4.6. Deletion of codY Gene and Its Effect on the Expression of yvfI in Bacillus 
subtilis 
The B. subtilis CodY protein has a global regulator effect on gene expression. CodY 
as a GTP-binding repressor of several genes is susceptive to the concentration of 
GTP in growing medium (Ratnayake-Lecamwasam et al., 2001). When 
concentration of GTP is high, then CodY becomes active.  On the other hand, when 
growth rate of B. subtilis slows down due to  limitation of the carbon or nitrogen or 
phosphorus source, then GTP level reduces (Lopez et al., 1979 and 1981). In this 
case CodY loses repressing activity, and hence the genes which are under CodY 
repression become actively transcribed. 
CodY represses early-stationary phase genes under excess nutrition condition and 
ability of codY mutant strains for sporulation and genetic competence development 
even though there is a nutrition excess,  points out that CodY has a key role in 
regulation (Inaoka et al., 2002; Molle et al., 2003). CodY binding site in the srfA 
promoter region overlaps with the presumed RNA polymerase binding site but not 
with the ComA binding sites (Roggiani and  Dubnau, 1993). codY-null mutation in 
which srfA and comK were intact, CodY seems to be the inhibitor of srfA expression 
by blocking RNA polymerase activity.  This  suggestion  fits to  the supposition that  
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srfA expression is repressed by CodY in the presence of Casamino acids whether or 
not ComA is active (Serror and Sonenshein, 1996). 
In order to determine the effect of codY-null mutation on yvfI gene expression, codY 
was insertionally inactivated in Bacillus subtilis PY79 wild type strain via 
transformation. PY79 wild type strain was used as competent cell, and was 
transformed by chromosomal DNA of strain of TMH307 (∆codY::spc). The 
transformants were then screened both on agar plates containing Spc (100µg/ml) 
antibiotic and also with PCR with specific primers for codY (primers were listed in 
Table 2.2). Then selected ∆codY transformant was used as competent cell and was 
transformed by chromosomal DNA of TEK7 (yvfI::lacZ::erm). Then the 
transformants were  screened on X-gal (40 µg/ml)  IPTG containing agar plates for 
checking of lacZ activity, and also for SpcR (100 µg/ml). The selected mutant was 
named as ECU14 (yvfI::lacZ::erm trpC2 unkU::spc ∆codY).  
Then codY-abrB double mutant strain was constructed by using ECU14 as competent 
cell. ECU14 was transformed with chromosomal DNA of ∆abrB::cat mutant strain 
derivative of B. subtilis. The transformants were screened for double antibiotic 
resistance to  Spc (100 µg/ml) and Cm (5 µg/ml). The selected mutant was named as 
ECU2 (yvfI::lacZ::erm trpC2 unkU::spc ∆codY::∆abrB::cm). 
The resulting strain ECU14, ECU2 and TEK7, as the control, were cultured in PA 
medium and were sampled in 1 h intervals for the β-galactosidase activity assay. 
Growth curves were shown in Figure 3.22 and data of β-galactosidase activities was 
shown in the Figure  3.23, and Fig. 3.24. 
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Figure 3.22 :  Growth curves of TEK7 (yvfI::lacZ::erm), ECU2 (yvfI::lacZ::erm 
trpC2 unkU::spc ∆codY::∆abrB::cm) and ECU14 (yvfI::lacZ::erm 
trpC2 unkU::spc ∆codY) straing grown in PA medium. The symbols 
used for strains are; (■) TEK7 (yvfI::lacZ::erm), (▲) ECU2 
(yvfI::lacZ::erm trpC2 unkU::spc ∆codY::∆abrB::cm) and (◊) ECU14 
(yvfI::lacZ::erm trpC2 unkU::spc ∆codY). 
 
                 
Figure 3.23 :  β-Galactosidase activities of TEK7 and codY-deleted mutant strain 
grown in PA medium and effect of deletion on yvfI-lacZ expression. 
The symbols used for the strains are; (▲) TEK7 (yvfI::lacZ::erm) 
and (■) ECU14 (yvfI::lacZ::erm trpC2 unkU::spc ∆codY). 
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 Deletion result of codY-abrB genes is shown in the following figure (Fig. 3.24).  
        
                  
Figure 3.24 :  β-Galactosidase activities of TEK7 and codY-abrB-deleted mutant 
strain grown in PA medium and effect of deletion on yvfI-lacZ 
expression. The symbols used for the strains are; (■) TEK7 
(yvfI::lacZ::erm) and (▲) ECU2 (yvfI::lacZ::erm trpC2 unkU::spc 
∆codY::∆abrB::cm) 
 
As seen in Fig. 3.23 in codY-disrupted strain, yvfI::lacZ expression has decreased 
exponentially, but the most strong supression was monitored during the stationary 
phase. Similarly  abrB deletion resulted in nearly same repression profile in yvfI 
expression (Fig. 3.19). However, in the case of deletion of both codY and abrB 
genes, overproducing of yvfI was observed (Fig. 3.24). This data has given rise to the 
opinion that yvfI gene might be under mutual control of those both genes.  
On the other hand, in order to examine the nutritional regulation system on both 
conditions, in presence and absence of codY gene, casaminoacid (casein) addition 
was applied. So casein was added into growth medium of ECU14, and also TEK7 
was used as control group. 
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Figure 3.25 :     Growth curve of TEK7 (yvfI::lacZ::erm) strain grown in PA medium  
within and without casein, seperately. The symbols used for the 
strains are; (▲) TEK7 (yvfI::lacZ::erm) without casein, (∆)TEK7 
(yvfI::lacZ::erm) within casein. 
              
Figure 3.26 :     Growth  curve of   ECU14 (yvfI::lacZ::erm trpC2 unkU::spc ∆codY) 
strain grown in PA medium within and without casein.  The symbols 
used for the strains are; (■) ECU14 (yvfI::lacZ::erm trpC2 unkU::spc 
∆codY) without casein, (□) ECU14 (yvfI::lacZ::erm trpC2 unkU::spc 
∆codY) within casein.
 
50
The effects of casein addition are shown in the following figures ( Fig. 3.27 and Fig. 
3.28).  
                 
Figure 3.27 :    β-Galactosidase activities of TEK7 (yvfI::lacZ::erm) strain grown in 
PA medium within and without casein, seperately. The symbols used 
for the strains are; (■) TEK7 (yvfI::lacZ::erm) without casein, 
(▲)TEK7 (yvfI::lacZ::erm) within casein. 
 
                 
Figure 3.28 :  β-Galactosidase activities of ECU14 (yvfI::lacZ::erm trpC2 unkU::spc 
∆codY)  strain grown in PA medium within and without casein, 
seperately. The symbols used for the strains are; (■) ECU14 
(yvfI::lacZ::erm trpC2 unkU::spc ∆codY)  without casein, (▲) ECU14 
(yvfI::lacZ::erm trpC2 unkU::spc ∆codY) within casein. 
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As can be seen in Fig. 3.25 and Fig. 3.26, casein supplementation has accelerated 
growth during the exponential phase in both mutant strain, TEK7 and ECU14. 
Nevertheless, both in TEK7 and ECU14 mutants, yvfI expression was observed to be 
supressed with the addtion of extra casamino acid (Fig. 3.27, Fig. 3.28). Knowing 
that CodY is a very strong element of nutritional regulation circuit, repression of yvfI 
expression was expected in TEK7 when the growth medium is supplemented with 
casein considering the presence of intact CodY protein. On the other hand, a relief in 
supresion was expected in ∆codY strain, ECU14. In contrast with this expectation, 
specific expression of yvfI in ECU14 was severely abolished in stationary phase even 
though codY was deleted. Therefore, it might be an evidence for the presence of 
another strong supressor, which is effective on yvfI gene regulation. When 
overexpression of yvfI in ECU2 mutant strain (∆codY- ∆abrB mutant) is considered, 
then AbrB might be thought to be the second regulator assisting to CodY for 
repression of yvfI gene. 
3.4.7. Deletion of degU Gene and Its Effect on the Expression of yvfI Gene in 
Bacillus subtilis 
The B.subtilis DegS–DegU two-component system positively regulates many cellular 
processes including exoprotease production, competence development and motility, 
dependent on DegU response regulator. Some target genes expression is stimulated 
by phosphorylated DegU, while some is triggered by unphosphorylated DegU 
(Msadek et al.,  1995). 
Furthermore, degU and degS mutations stimulate degradative enzyme synthesis and 
inhibit competence (Msadek et al., 1990; Dahl et al., 1991). While one class of 
mutations leads to deficiency of degradative enzyme synthesis (degS or degU 
mutations), the second one leads to overproduction of degradative enzymes causing 
cells to sporulate even though there is presence of glucose, loss of flagella, and 
decreased genetic competence (Msaek et al., 1990). Also degU mutation decreases 
the expression of srfA, an essential competence regulatory gene (Dubnau, 1991; Dahl 
et al., 1992). 
In order to examine the effect of degU null mutation, degU gene was deleted in the 
transcriptional yvfI::lacZ fusion strain TEK7. For this  purpose, TEK7 was  used  
ascompetent cell, then was transformed with the chromosomal DNA of ∆degU::kan 
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mutant derivative of B. subtilis. The transformants were selected with regard to 
specific antibiotic resistance for Kan (10 µg/ml). As a consequence, selected mutant 
was named as ECU8 (yvfI::lacZ::erm ∆degU::erm). 
               
Figure 3.29 : Growth curves of TEK7 (yvfI::lacZ::erm) and ECU8 (yvfI::lacZ::erm 
∆degU::erm) strains grown in PA medium. The symbols used for the 
strains are; (▲) TEK7 (yvfI::lacZ::erm) an (∆) ECU8 (yvfI::lacZ::erm 
∆degU::erm). 
 
           
Figure 3.30 :   β-Galactosidase activities of TEK7 and degU-deleted mutant strain 
grown in PA medium and effect of deletion on yvfI-lacZ expression. 
The symbols used for the strains are; (■) TEK7 (yvfI::lacZ::erm) and 
(▲) ECU8 (yvfI::lacZ::erm ∆degU::erm). 
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As seen in Fig 3.30,  yvfI expression was almost fully blocked when degU gene was 
targeted for deletion. DegU is an effective positive regulator of srf operon, therefore, 
it is proposed that expression of yvfI has required degU gene as well as srfA gene.  
3.4.8. Deletion of sigmaB  Gene and Its Effect on the Expression of yvfI Gene in 
Bacillus subtilis 
The sigB gene product, σB is activated by metabolic stress conditions or 
environmental signals at the end of logarithmic growth. In order to monitor the effect 
of sigB null mutation, sigB gene was deleted in the transcriptional yvfI::lacZ fusion 
strain TEK7. For this purpose, TEK7 was used as competent cell, then was 
transformed with thw chromosomal DNA of ∆ML6::cm (sigB::cm) mutant derivative 
of B. subtilis. The transformants were selected with regard to specific antibiotic 
resistance for Cm (5µg/ml). Later on, the selected mutant was named as ECU7 
(yvfI::lacZ::erm ∆ML6::cm). 
 
         
Figure 3.31 :  Growth curves of TEK7 (yvfI::lacZ::erm) and ECU7  (yvfI::lacZ::erm 
∆ML6::cm) strains grown in PA medium. The symbols used for the 
strains are; (□) TEK7 (yvfI::lacZ::erm) an (■) ECU8 (yvfI::lacZ::erm 
∆ML6::cm). 
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Figure 3.32 :  β-Galactosidase activities of TEK7 and sigB-deleted mutant strain 
grown in PA medium and effect of deletion on yvfI-lacZ expression. 
The symbols used for the strains are; (■) TEK7 (yvfI::lacZ::erm) and 
(□) ECU7 (yvfI::lacZ::erm ∆sigB::cm). 
 
As observed in Fig. 3.32, sigB deletion mutation did not seriously affect yvfI gene 
expression. Product of this gene, SigmaB, was required in response to excessive 
conditions such as salt, acid, heat. Therefore, this observation indicated that SigmaB 
was not an alternative subunit needed for yvfI expression. 
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4. CONCLUSION 
In this present study, in order to monitor expression of yvfI,  the yvfI::lacZ fusion 
mutant was constructed (TEK7)  and the yvfI::lacZ expression was measured using 
beta-galactosidase activity assay in PA medium. In the result of assay, yvfI 
expression was slowly increased during the exponential growth and reached to 
maximum level during the transition upon entry into stationary phase. 
In order to identify the effects of global regulatory genes on the expression of yvfI 
gene, these genes were deleted via transformation of competent cells of TEK7 with 
chromosomal DNAs of the corresponding blocked mutant strains and yvfI-directed β-
galactosidase activities were subsequently analyzed. 
The deletion of srfA gene resulted in the completely elimination of yvfI-lacZ 
expression, suggesting that fully expression of yvfI gene requires intact surfactin 
operon. 
In disruption of oppA gene, yvfI-lacZ expression severely abolished, indicating that 
product of oppA gene regulates yvfI gene expression as a part of quorum sensing 
mechnanism  
The blockage of phrC, phrF and phrK genes affected yvfI-lacZ expression seriously. 
Depending on this result, it was suggested that the pheromone peptides Phr C, F and 
K are essential for yvfI gene expression, most likely by enhancing the full activation 
of transcriptional factor ComA~P. 
 In the result of comA, comP, comQ and spo0H genes deletion, yvfI-lacZ expression 
entirely impaired, indicating that products of those genes has regulating effects on 
the expression of yvfI. Considering that ComP and ComX (ComQ) involved in 
ComA phosphorylation and activation, in addition, σH required for increased level of 
phr gene during transition state in order to induce activation of ComA, it is proposed 
that yvfI  might be transcribed in a ComA~P-dependent manner. 
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spo0A and abrB genes were examined through the disruption of those genes in TEK7 
strain. In the expression of yvfI-lacZ fully eliminated in spo0A mutant strain, a relief 
was monitored during exponential growth, but contrarily, in stationary phase severe 
repression of yvfI-lacZ expression was observed in the expression profile of abrB 
mutant strain, and yvfI-lacZ expression was abolished completely in spo0A-abrB 
double mutant strain. Depending on these findings, we indicated that both AbrB and 
Spo0A activities are required for the induction and maximum yvfI expression at the 
onset of stationary phase. 
In codY gene deletion, decreased yvfI-lacZ expression during exponential phase, and 
strongly decreased yvfI-lacZ expression during the stationary phase was monitored in 
the codY-disrupted strain. Moreover, deletion of both codY and abrB genes, resulted 
with overproduction of yvfI gene. In order to identify the nutritional regulation in the 
presence and absence of codY gene, casein was added as supplementery nutrient 
source in PA medium, resulted in the similar yvfI expression profile in yvfI-lacZ 
fusion strain and codY-disrupted strain. Thereupon, we proposed that those results 
might be an evidence for presence of another strong supressor effective on yvfI gene 
regulation, having a good candidate as AbrB. 
As a result of  degU gene deletion in TEK7 strain, yvfI expression was almost fully 
blocked. Therefore, we suggested that DegU positively regulates the expression of 
yvfI. 
Finally, sigB deletion mutation did not seriously affect yvfI gene expression, 
indicating that SigmaB was not an alternative subunit needed for yvfI expression. 
 
 
 
57
 
REFERENCES 
Abrahart, R. J., and See, L., 1998: Neural Network vs. ARMA Modelling: 
Constructing Benchmark Case Studies of River Flow Prediction. In 
GeoComputation ’98. Proceedings of the Third International 
Conference on GeoComputation, University of Bristol, United 
Kingdom, 17–19 September (CD-ROM). 
Ansaldi, M., Marolt, D., Stebe, T., Mandic-Mulec, I., and Dubnau, D., 2002. 
Specific activation of the Bacillus quorum-sensing systems by 
isoprenylated pheromone variants. Molecular Microbiology, 44, 6, 
1561-1573.    
Auchtung, J. M.,  Lee, C. A.,  and Grossman, A. D., 2006.  Modulation of the 
ComA-Dependent Quorum Response in Bacillus subtilis by Multiple 
Rap Proteins and Phr Peptides. Journal of Bacteriology, Vol. 188, No. 
14, 5273-5285.  
Banse, A. V., Chastanet, A., Rahn-Lee, L., Hobbs, E. C.,  and  Losick, R., 2008. 
Parallel pathways of repression and antirepression governing the 
transition to stationary phase in Bacillus subtilis.  Proc Natl Acad Sci., 
7, 105, 40, 15547-52.   
Basalp, A., Özcengiz, G., and Alaeddinoglu, N. G., 1992. Changes in patterns of 
alkaline serine protease and bacilysin formation caused by common 
effectors of sporulation in Bacillus subtilis 168. Curr Microbiol., 24, 
129-135. 
Bodman, S. B., Willey, J. M., and Diggle, S. P., 2008. Cell-Cell Communication in 
Bacteria: United We Stand. Journal of Bacteriology, Vol. 190, no. 13, 
4377–4391.   
Bongiorni, C., Ishikawa, S., Stephenson, S., Ogasawara, N.,  and Perego, M.,  
2005. Synergistic regulation of competence development in Bacillus 
subtilis by two Rap-Phr systems. J. Bacteriol., 187, 4353-4361 
Boylan, S. A., Rutherford, A., Thomas, S. M., and  Price, C. W., 1992. Activation 
of Bacillus subtilis Transcription Factor 0FB by a Regulatory Pathway 
Responsive to Stationary-Phase Signals. Journal of Bacteriology, Vol. 
174, No. 11, 3695-3706 
Burbulys, D., Trach, K. A., and  Hoch, J. A., 1991. Initiation of sporulation in B. 
subtilis is controlled by a multicomponent phosphorelay. Cell 64, 
545–552.  
Camara, M., 2006. Quorum Sensing: A Cell-Cell Signalling Mechanism Used to 
Coordinate Behavioral Changes in Bacterial Populations. Workshop 
on Membrane Computing 2006, 42-48.   
 
58
Carter, H. L., Tatti, K. M., and Moran, C. P., 1990. Cloning of a promoter used 
by sigma-H RNA polymerase in Bacillus subtilis. Gene,  96, 101-105. 
Cashel, M., Gentry, D., Hernandez, V., and Vinella, D., 1996. The stringent 
response. In Escherichia coli and Salmonella, (pp. 1458–1496), ASM 
Press. 
Chmara, H., 1985. Inhibition of glucosamine synthase by bacilysin and anticapsin. J 
Gen Microbiol., 131, 265-271. 
Chmara, H., Woynarowska, and B., Borowski, E., 1981. Epoxypeptide antibiotic 
tetaine mimics peptides in transport to bacteria. J Antibiot., 34, 1608-
1612.  
Core, L., and Perego, M., 2003. TPR-mediated interaction of RapC with ComA 
inhibits response regulator -DNA binding for competence 
development in Bacillus subtilis. Mol. Microbiol., 49, 1509-1522. 
Cosby, W. M., Vollenbroich, D., Lee, O. H., and Zuber, P., 1998. Altered srf 
Expression in Bacillus subtilis Resulting from Changes in Culture pH 
Is Dependent on the Spo0K Oligopeptide Permease and the ComQX 
System of Extracellular Control.Journal of Bacteriology, Vol. 180, 
No. 6, 1438-1445.  
Dahl, M. K., Msadek, T., Kunst, F.,  and Rapoport, G., 1991. Mutational analysis 
of the Bacillus subtilis DegU regulator and its phosphorylation by the 
DegS protein kinase. J. Bacteriol., 173, 2539-2547. 
Dahl, S., Msadek, T., Kunst, F.,  and Rapoport, G., 1992. The Phosphorylation 
State of the DegU Response Regulator Act as a Molecular Switch 
Allowing Either Degradative Enzyme Synthesis or Expression of 
Genetic Competence in Bacillus subtilis. J. Biol. Chem., Vol. 267, No. 
20, 14509-14514. 
Diggle, S. P., Gardner, A., West, S. A., and Griffin, A. S., 2007. Evolutionary 
theory of bacterial quorum sensing: when is a signal not a signal?. 
Phil. Trans. R. Soc. B, 1-9  
Dubnau, D., 1991.  Genetic competence in Bacillus subtilis. Microbiol.Mol. Biol. 
Rev., 55, 3, 395-424. 
Dubnau, D., 1991. The regulation of genetic competence in Bacillus subtilis. Mol. 
Microbiol., 5, 11-18. 
Dunny, G. M., and Winans, S. C., 1999. Cell-cell Signaling in Bacteria(pp. 31-33). 
ASM Press.  
Earl, A. M., Losick, R., and Kolter, R., 2008. Ecology and genomics of Bacillus 
subtilis. Trends Microbiol., 16/6, 269-275    
Ferrari, E., Jarnagin, A. S., and Schmidt, B. F., 1993. Commercial production of 
extracellular enzymes. In: Bacillus subtilis and other Gram-positive 
bacteria. Biochemistry, physiology, and molecular genetics, (pp. 917–
937), American Society for Microbiology. 
Fujita, M., Gonzalez-Pastor, J. E., and Losick, R., 2005.  High- and Low-
Threshold Genes in the Spo0A Regulon of Bacillus subtilis. Journal  
of Bacteriology, Vol. 187, No. 4, 1357-1368. 
 
59
Fujiya, M., Musch, M. W., Nakagawa, Y., Hu, S., Alverdy, J., Kohgo, Y., 
Schneewind, O., Jabri, B., and Chang, E. B., 2007. The Bacillus 
subtilis Quorum-Sensing Molecule CSF Contributes to Intestinal 
Homeostasis via OCTN2, a Host Cell Membrane Transporter, Cell 
Host & Microbe 1, 299–308.  
Fuma, S., Fujishima, Y., Corbell, N., D’Souza, C., Nakano, M. M., Zuber, P., 
and Yamane, K., 1993. Nucleotide sequence of 59 portion of srfA 
that contains the region required for competence establishment in 
Bacillus subtilis. Nucleic Acids Res., 21, 93-97. 
Galli, G., Rodriguez, F., Cosmina, P., Pratesi, C., Nogarotto, R., de Ferra, F., 
and Grandi, G., 1994. Characterization of the surfactin synthetase 
multienzyme complex. Biochim. Biophys. Acta., 120, 19-28. 
Glaser, P., Danchin, A., Kunst, F., Zuber, P., and Nakano, M. M., 1995. 
Identification and Isolation of a Gene Required for Nitrate 
Assimilation and Anaerobic Growth of Bacillus subtilis. Journal Of 
Bacteriology, 177, 4, 1112-1115.     
Griffith, L. K., and Grossman, A. D., 2008. A Degenerate Tripartite DNA-Binding 
Site Required for Activation of ComA-Dependent Quorum Response 
Gene Expression in Bacillus subtilis. J. Mol. Biol., 381, 261–275.   
Guespin-Michel, J. F., 1971. Phenotypic Reversion in Some Early Blocked 
Sporulation Mutants of Bacillus subtilis: Isolation and Phenotype 
Identification of Partial Revertants. Journal  of Bacteriology, Vol. 
108, No. 1,  241-247. 
Hahn, J., and Dubnau, D., 1991. Growth Stage Signal Transduction and the 
Requirements for srfA Induction in Development of Competence. 
Journal of Bacteriology., Vol. 173, No. 22, 7275-7282. 
Havarstein, S. L., 2003. Intercellular Communication in Gram-Positive Bacteria 
Depends on Peptide Pheromones and Their Histidine Kinase 
Receptors. Chapter of Histidine Kinases in Signal Transduction, 
chapter no. 16, 341-363. 
Helmann, J. D., and Chamberlin, M. J., 1988. Structure and function of bacterial 
sigma factors. Annu. Rev. Biochem., 57, 839-872. 
Hilton, M. D., Alaeddinoglu, N. G., and Demain, A. L., 1988.  Synthesis of 
bacilysin by Bacillus subtilis branches from the prephenate of the 
aromatic amino acid pathway. J Bacteriol., 170, 482-484. 
Hoch, J. A., 1993. Regulation of the phosphorelay and the initiation of sporulation in 
Bacillus subtilis. Annu. Rev. Microbiol,. 47, 441–465.   
Hoch, J.A., 1995. Control of cellular development in sporulating bacteria by the 
phosphorelay two-component signal transduction system. In: Two-
component Signal Transduction (pp. 129-144). American Society for 
Microbiology. 
Hong, H.A., Duc, L.H., and Cutting, S.M., 2005. The use of bacterial spore 
formers as probiotics. FEMS Microbiol. Rev., 29, 813–835. 
 
60
Hoskisson, P. A., Rigali, S., Fowler, K., Findlay, K. C., and Buttner, M. J., 2006. 
DevA, a GntR-Like Transcriptional Regulator Required for 
Development in Streptomyces coelicolor. Journal of Bacteriology, 
Vol. 188, No. 14, 5014-5023.  
Inaoka, T., Takahashi, K., Ohnishi-Kameyama, M., Yoshida, M., and Ochi, K., 
2003. Guanine nucleotides guanosine 5’-diphosphate 3’-diphosphate 
and GTP co-operatively regulate the production of an antibiotic 
bacilysin in Bacillus subtilis. J Biol Chem., 278, 2169-2176. 
Inaoka, T., and Ochi., 2002. RelA Protein Is Involved in Induction of Genetic 
Competence in Certain Bacillus subtilis Strains by Moderating the 
Level of Intracellular GTP. Journal of Bacteriology, Vol. 184, No. 14, 
3923-3930. 
Inouye, M., and Dutta, R., 2002.Histidine Kinases in Signal Transduction, (pp 313-
340), Academic Press.   
Ireton, K., Rudner, D. Z., Siranosian, K. J., and Grossman, A. D., 1993. 
Integration of multiple developmental signals in Bacillus subtilis 
through the Spo0A transcription factor. Genes Dev., 7, 283-294. 
Isenberg, H. D., Hoch, J. A., Sonenshein, A. L., Losick, R., 1993. Bacillus subtilis 
and other gram-positive bacteria: biochemistry, physiology and 
molecular genetics. (pp 747-755). American Society for Microbiology  
Jaacks, K. J., Healy, J., Losick, R., and Grossman, A. D., 1989. Identification and 
characterization of genes controlled by the sporulation-regulatory 
gene spo0H in Bacillus subtilis. J. Bacteriol., 171, 4121-4129. 
Jiang, M., Grau, R.,  and Perego, M., 2000. Differential processing of propeptide 
inhibitors of Rap phosphatases in Bacillus subtilis. J. Bacteriol., 182, 
303-310  
Kalman, S., Duncan, M. L., Thomas, S. M., and Price, C. W., 1990. Similar 
organization of the sigB and spoIIA operons encoding alternate sigma 
factors of Bacillus subtilis RNA polymerase. J. Bacteriol.,  172, 5575-
5585. 
Kenig, M., and Abraham, E. P., (1976) Antimicrobial activities and antagonists of 
bacilysin and anticapsin. J Gen Microbiol., 94, 37-45. 
Kenig, M., Vandamme, E., and Abraham, E. P., 1976. The mode of action of 
bacilysin and anticapsin and biochemical properties of bacilysin-
resistant mutants. J Gen Microbiol., 94, 46-54. 
Kleerebezem, M., Quadri, L. E., Kuipers, O. P., de Vos, W. M., 1997. Quorum 
sensing by peptide pheromones and two-component signal 
transduction systems in Gram-positive bacteria. Mol Microbiol., 24, 
895-904. 
Klein, W., and Marahiel, M. A., 2002. Structure-Function Relationship and 
Regulation of Two Bacillus subtilis DNA-Binding Proteins, HBsu and 
AbrB J. Mol. Microbiol. Biotechnol.,  4, 3, 323-329. 
Kobayashi, K., and Ogasawara, N., 2002. Genome biology of a model bacterium, 
Bacillus subtilis, International Congress Series, 1246, 15–25   
 
61
Kobayashi, K., Ehrlich, S. D., Albertini, A.,  Amati, G., Andersen, K. K., 
Arnaud, M., Asai, K., Ashikaga, S., Aymerich, S., Bessieres, P., 
Boland, S. C., Brignell, Bron, S., Bunai, K., Chapuis, J., 
Christiansen, L C., Danchin, A., De´ barbouille, M., Dervyn, E., 
Deuerling, E., Devine, K., Devine, S. K., Dreesen, O.,  Errington, 
J., Fillinger, Foster, S. J., Fujita, Y.,  Galizzi, A., Gardan, R., 
Eschevins, C., Fukushima, T., Haga, K., Harwood, C. R., Hecker, 
M.,  Hosoya, D., Hullo, M. F., Kakeshita, H., Karamata, D., 
Kasahara, Y., Kawamura, F.,  Koga, K., Koski, P., Kuwana, R., 
Imamura, D., Ishimaru, M., Ishikawa, S., Ishio, I., Le Coq, D., 
Massona, A., Mauel, C., Meima, R., Mellado, R. P., Moirk, A., 
Moriya, S., Nagakawa, E., Nanamiya, H., Nakai, S., Nygaard, P., 
Ogura, M., Ohanan, T., O’Reilly, M., O’Rourke, M., Pragai, 
Pooley, Z., Rapoport, H. M., Rawlins, G.,  J. P., Rivas, L. A., 
Rivolta, C., Sadaie, A., Sadaie, Y., Sarvas, M., Sato, T., Saxild, H.  
H., Scanlan, E., Schumann, W., Seegers, J. F. M. L., Sekiguchi, J., 
Sekowska, A., Seror, S. J., Simon, M., Stragier, P., Studer, R., 
Takamatsu, H., Tanaka, T., Takeuchi, M., Thomaides, H. B., 
Vagner, V., van Dijl, J. M., Watabe, K., Wipat, A., Yamamoto, H., 
Yamamoto, M., Yamamoto, Y., Yamane, K., Yata, K., Yoshida, 
K., Yoshikawa, H., Zuber, U.,  and Ogasawara, N., 2003. Essential 
Bacillus subtilis genes. PNAS, Vol.100, no. 8, 4678-4683   
Köroğlu, T. E., Kurt-Gür, G., Ünlü, E. C., and Yazgan-Karataş, A., 2008. The 
novel gene yvfI in Bacillus subtilis is essential for bacilysin 
biosynthesis. Antonie van Leeuwenhoek,, 94, 3, 471-479. 
 
62
Kunst, F., Ogasawara, N, Moszer, I., Albertini, A.M., Alloni, G., Azevedo, V., 
Bertero, M.G., Bessiéres, P., Bolotin, A., Borchert, S., Borriss, R., 
Boursier, L., Brans, A., Braun, M., Brignell, S.C., Bron, S, 
Brouillet, S., Bruschi, C.V., Caldwell, B., Capuano, V., Carter, 
N.M., Choi, S.-K., Codani, J.-J., Connerton, I.F., Cummings, N.J., 
Daniel, R.A., Denizot, F., Devine, K.M., Düsterhöft, A., Ehrlich, 
S.D., Emmerson, P.T., Entian, K.D., Errington, J., Fabret, C., 
Ferrari, E., Foulger, D., Fritz, C., Fujita, M., Fujita, Y., Fuma, S., 
Galizzi, A., Galleron, A., Ghim, S.-Y., Glaser, P., Goffeau, A., 
Golightly,E.J., Grandi, G., Guiseppi, G., Guy, B.J., Haga, K., 
Haiech, J., Harwood, C.R., Hénaut, A., Hilbert, H., Holsappe, S., 
Hosono, S., Hullo, M.-F., Itaya, M., Jones, L., Joris, B., Karamata, 
D., Kasahara, Y., Klaerr-Blanchard, M., Klein, C., Kobayashi, Y., 
Koetter, B., Koningstein, G., Krogh, S., Kumano, M., Kurita, K., 
Lapidus, A., Lardinois, S., Lauber, J., Lazarevic, V., Lee, S.-M., 
Levine, A., Liu, H., Masuda, S., Mauel, C., Médigue, C., Medina, 
N., Mellado, R.P., Mizuno, M., Moest, D., Nakai, S., Noback, M., 
Noone, D., O’Reilly, M., Ogawa, K., Ogiwara, A., Oudega, B., 
Park, S.-H., Parro, V., Pohl, T.M., Portetelle, D., Porwollik, S., 
Prescott, A.M., Presecan, E., Pujic, P., Purnelle, B., Rapoport, G., 
Rey, M., Reynolds, S., Rieger, M., Rivolta, C., Rocha, E., Roche, 
B., Rose, M., Sadaie, Y., Sato, T., Scanlan, E., Schleich, S., 
Schroeter, R., Scoffone, F., Sekiguchi, J., Sekowska, A., Seror, 
S.J., Serror, P., Shin, B.-S., Soldo, B., Sorokin, A., Tacconi, E., 
Takagi, T., Takahashi, H., Takemaru, K., Takeuchi, M., 
Tamakoshi, A.,Tanaka, T., Terpstra, P., Tognoni, A., Tosato, V., 
Uchiyama, S., Vandenbol, M., Vannier, F., Vassarotti, A., Viari, 
A., Wambutt, R., Wedler, E., Wedler, H., Weitzenegger, T., 
Winters, P., Wipat, A., Yamamoto, H., Yamane, K., Yasumoto, 
K., Yata, K., Yoshida, K., Yoshikawa, H.-F., Zumstein, E., 
Yoshikawa, H., and Danchin, A., 1997. The complete genome 
sequence of the Gram-positive bacterium Bacillus subtilis. Nature, 
390, 249-256. 
Lazazzera, B. A.,  2001. The intracellular function of extracellular signaling 
peptides. Peptides, 22, 1519-1527  
Lazazzera, B. A., 2000. Quorum sensing and starvation: signals for entry into 
stationary phase. Current Opinion in Microbiology, 3, 177-182     
Lazazzera B. A., Grossman, A. D., 1998. The ins and outs of peptide signaling. 
Trends Microbiol, 6, 288-294. 
Lazazzera, B. A., Kurtser, I. G., McQuade, R. S., Grossman, A. D., 1999. An  
autoregulatory circuit affecting peptide signaling in Bacillus subtilis. J 
Bacteriol., 181, 5193-5200. 
Lazazzera, B. A., Solomon J. M., Grossman A.D., 1997. An exported peptide 
functions intracellularly to contribute to cell density signaling in B. 
subtilis. Cell 89, 917-925. 
Lazdunski, M A., Ventre, I., and Sturgis, J. N., 2004. Regulatory Circuits and 
Communication in Gram-Negative Bacteria. Nature Reviews 
Microbiology 2, 581-592. 
 
63
LeDeaux, J. R., Solomon, J. M., and Grossman, A. D., 1997. Analysis of non-
polar deletion mutations in the genes of the spo0K (opp) operon of 
Bacillus subtilis FEMS Microbiology Letters, Vol. 153, No. 1, 63-69. 
LeDeaux, J. R., Yu, N., and Grossman, A. D., 1995. Different Roles for KinA, 
KinB, and KinC in the Initiation of Sporulation in Bacillus subtilis. 
Journal of Bacteriology, Vol. 177, No. 3, 861-863. 
Lopez, J. M., Dromerick, A., and Freese, E., 1981. Response of guanosine 5’-
triphosphate concentration to nutritional changes and its significance 
for Bacillus subtilis sporulation. J. Bacteriol., 146, 605-613. 
Lopez, J. M., Marks, C. L., and Freese, E., 1979. The decrease of guanine 
nucleotides initiates sporulation of Bacillus subtilis. Biochim. Biophys. 
Acta., 587, 238–252. 
Magnuson, R., Solomon, J., and Grossman, A. D., 1994. Biochemical and genetic 
characterization of a competence pheromone from B. subtilis Cell, 
Vol. 77, 2, 207-216  
Marahiel, M. A., 1997. Protein templates for the biosynthesis of peptide antibiotics. 
Chem. Biol., 4, 561-567. 
Marchler-Bauer, A., Anderson, J. B., Cherukuri, P. F., DeWeese-Scott, C., 
Geer, L. Y., Gwadz, M., He, S., Hurwit,z D. I., Jackson, J. D., Ke, 
Z., Lanczycki, C. J., Liebert, C. A., Liu, C., Lu, F., Marchler, G. 
H., Mullokandov, M., Shoemaker, B. A., Simonyan, V., Song, J. S., 
Thiessen, P. A., Yamashita, R. A., Yin, J. J., Zhang, D., an d 
Bryant, S. H., 2005. CDD: a Conserved Domain Database for protein 
classification. Nucleic Acids Res.,33, 192-196. 
Marten, P., Smalla, K., and Berg, G., 2000. Genotypic and phenotypic 
differentiation of an antifungal biocontrol strain belonging to Bacillus 
subtilis.  Journal of Applied Microbiology, 89, 463-471.  
Msadek T., Kunst, F.,  and Rapoport, G., 1995. A signal transduction network in 
Bacillus subtilis includes the DegS/DegU and ComP/ComA two-
component systems. In: Two-Component Signal Transduction, (pp. 
447-471), American Society for Microbiology. 
Msadek, T., Kunst, F., Henner, D., Klier, A., Rapoport, G., and Dedonder, R., 
1990. Signal transduction pathway controlling synthesis of a class of 
degradative enzymes in Bacillus subtilis: expression of the regulatory 
genes and analysis of mutations in degS and degU. J. Bacteriol., 172, 
824-834. 
Molle, V., Fujita, M., Jensen,  S. T., Eichenberger, P., González-Pastor, J. E., 
Liu, J. S., and Losick, R., 2003. The Spo0A regulon of Bacillus 
subtilis. Molecular Microbiology, 50, 5, 1683-1701. 
Molle, V., Nakaura, Y., Shivers, R. P., Yamaguchi, H., Losick, R., Fujita, Y., 
and Sonenshein, A. L., 2003. Additional Targets of the Bacillus 
subtilis Global Regulator CodY Identified by Chromatin 
Immunoprecipitation and Genome-Wide Transcript Analysis. Journal 
of Bacteriology, Vol. 185, No. 6, 1911-1922.  
 
64
Nakano, M. M., and Zuber, P., 1989. Cloning and characterization of srfB, a 
regulatory gene involved in surfactin production and competence in 
Bacillus subtilis. J. Bacteriol., 171, 5347-5353. 
Nakano, M. M., Magnuson, R., Myers, A., Curry, J., Grossman, A. D., and 
Zuber,  P., 1991. srfA is an operon required for surfactin production, 
competence development, and efficient sporulation in Bacillus 
subtilis. J. Bacteriol., Vol. 173, No. 5, 1770-1778. 
Nakano, M. M., Xia, L., and Zuber, P., 1991. Microbiology Transcription 
Initiation Region of the srfA Operon, Which Is Controlled by the 
comP-comA Signal Transduction System in Bacillus subtilis. Journal 
of Bacteriology,. Vol. 173, No. 17, 5487-5493. 
Nealson, K. H., and Hastings, J. W., 1979. Bacterial Bioluminescence: Its Control 
and Ecological Significance Microbiological Reviews, Vol. 43, no. 4, 
496-518 
Nealson, K. H., Platt, T., and Hasting, W., 1970. Cellular Control of the Synthesis 
and Activity of the Bacterial Luminescent System. Journal of 
Bacteriology, Vol.104, no. 1, 313-322. 
Ochi, K., and Freese, E., 1983. Effect of antibiotics on sporulation caused by the 
stringent response in Bacillus subtilis. J. Gen. Microbiol., 129, 3709-
3720. 
Ochi K., Kandala, J. C., and Freese, E., 1982.  Evidence that Bacillus subtilis 
sporulation induced by the stringent response is caused by the 
decrease in GTP or GDP. J. Bacteriol., 151, 1062-1065. 
Ogura, M., Yamaguchi, H., Yoshida, K. I., Fujita, Y., and Tanaka, T., 2001. 
DNA microarray analysis of Bacillus subtilis DegU, ComA and PhoP 
regulons: an approach to comprehensive analysis of B.subtilis two-
component regulatory systems. Nucleic Acids Res.,29, 18, 3804-3813. 
Özcengiz, G., Alaeddinoglu, N. G., and Demain, A. L., 1990. Regulation of 
biosynthesis of bacilysin by Bacillus subtilis. J Ind Microbiol., 6, 91-
100. 
Özcengiz, G., and Alaeddinoglu, N. G., 1991. Bacilysin production by Bacillus 
subtilis: effects of bacilysin, pH and temperature. Folia Microbiol., 
36, 522-526. 
Özcengiz, G., and Alaeddinoglu, N. G., 1991. Bacilysin production and sporulation 
in Bacillus subtilis. Curr Microbiol., 23, 61-64. 
Parsek, M. R., Greenberg, E. P., 2000. Acyl-homoserine lactone quorum sensing in 
Gram-negative bacteria: A signaling mechanism involved in 
associations with higher organisms. PNAS, Vol. 97, no. 16, 8789-
8793. 
Perego, M., 1997. A peptide export-import control circuit modulating bacterial 
development regulates protein phosphatases of the phosphorelay. Proc 
Natl Acad Sci, 94, 8612-8617. 
 
 
65
Perego, M., and Brannigan, J. A., 2001. Pentapeptide regulation of 
aspartylphosphate phosphatases. Peptides, 22, 1541-1547 
Perego, M., and Hoch, J. A., 1996. Cell-cell communication regulates the effects of 
protein aspartate phosphatases on the phosphorelay controlling 
development in Bacillus subtilis. Proc. Natl. Acad. Sci. USA, 93, 
1549-1553.  
Perego, M., and Hoch, J. A., 1996. Protein aspartate phosphatases control the 
output of two-component signal transduction systems. Trends Genet., 
12, 97-101. 
Perego, M., Hanstein, C. G., Welsh, K. M., Djavakhishvili, T., Glaser, P., and  
Hoch, J. A., 1994. Multiple protein-aspartate phosphatases provide a 
mechanism for the integration of diverse signals in the control of 
development in B. subtilis Cell 79, 6, 1047–1055. 
Perego, M., Glaser, P., and Hoch, J. A., 1996. Aspartyl-phosphate phosphatases 
deactivate the response regulator components of the sporulation signal 
transduction system in Bacillus subtilis. Mol. Microbiol., 19, 1151-
1157. 
Perry, D., and Abraham, E. P., 1979. Transport and metabolism of bacilysin and 
other peptides by suspensions of Staphylococcus aureus. J Gen 
Microbiol., 115, 213–221. 
Phillips, Z. E., and Strauch, M. A., 2002. Bacillus subtilis sporulation and 
stationary phase gene expression. Cell. Mol. Life Sci., 59, 392-402. 
Piazza, F., Tortosa, P.,  and Dubnau, D.,  1999. Mutational analysis and membrane 
topology of ComP, a quorum-sensing histidine kinase of Bacillus 
subtilis controlling competence development. J. Bacteriol., 181, 4540-
4548.   
Pottathil, M., Jung, A., and Lazazzera, B. A., 2008. CSF, A Species-Specific 
Extracellular Signaling Peptide for Communication among Strains of 
Bacillus subtilis and Bacillus mojavensis. Journal of Bacteriology, 
Vol. 190, no. 11, 4095–4099 
Price, C. W.,  2002. The general stress response. In Bacillus subtilis and its closest 
relatives: from genes to cells, (pp. 369–384), ASM Press. 
Ramos, H. C., Boursier, L., Moszer., Kunst, F., Danchin, A., and Glaser, P., 
1995. Anaerobic transcription activation in Bacillus subtilis: 
identification of distinct FNR-dependent and -independent regulatory 
mechanisms. The EMBO Journal, 14, 23, 5984-5994. 
Ratnayake-Lecamwasam, M., Serror, P., Wong, K. W., and Sonenshein, A. L., 
2001. Bacillus subtilis CodY represses early-stationary-phase genes 
by sensing GTP levels Genes & Dev., 15, 1093-1103. 
Roggiani, M., and Dubnau, D., 1993. ComA, a phosphorylated response regulator 
protein of Bacillus subtilis, binds to the promoter region of srfA. J. 
Bacteriol., 175, 3182-3187. 
Roggiani, M., Hahn, J., and Dubnau, D., 1990. Suppression of early competence 
mutations in Bacillus subtilis by mec mutations. J. Bacteriol., 172, 
4056-4063. 
 
66
Rudner, D. Z., LeDeaux, J. R., Ireton, K., and Grossman, A. D., 1991. The spo0K 
locus of Bacillus subtilis is homologous to the oligopeptide permease 
locus and is required for sporulation and competence. J. Bacteriol., 
173, 1388-1398. 
Sakajoh, M., Solomon, N. A., and Demain, A. L., 1987. Cell-free synthesis of the 
dipeptide antibiotic bacilysin. J Ind Microbiol., 2, 201-208. 
Schauder, S., Shokat, K., Surette, M. G.,  and Bassler, B. L., 2001. The LuxS 
family of bacterial autoinducers: biosynthesis of a novel quorum-
sensing signal molecule Molecular Microbiology, 41(2), 463-476   
Schneider, K. B., Palmer, T. M., and Grossman, A. D., 2002. Characterization of 
comQ and comX, Two Genes Required for Production of ComX 
Pheromone in Bacillus subtilis. Journal of Bacteriology, Vol. 184, no. 
2, 410-419.  
Serror, P., and Sonenshein, A. L., 1996. CodY Is Required for Nutritional 
Repression of Bacillus subtilis Genetic Competence. Journal of 
Bacteriology, Vol. 178, No. 20, 5910-5915.  
Shafikhani, S. H.,  and Leighton, T., 2004.   AbrB and Spo0E Control the Proper 
Timing of Sporulation in Bacillus subtilis. Current Microbiology, Vol. 
48, No. 4, 262-269. 
Shapiro, J. A., 1998. Thinking about bacterial populations as multicellular 
organisms. Annu. Rev. Microbiol, 52, 81–104.   
Shivers, R. P.,  and Sonenshein, A. L., 2004. Activation of the Bacillus subtilis 
global regulator CodY by direct interaction with branched-chain 
amino acids. Mol. Microbiol. 53, 2, 599-611. 
Solomon, J. M., Lazazzera, B. A.,  and Grossman, A. D., 1996. Purification and 
characterization of an extracellular peptide factor that affects two 
different developmental pathways in Bacillus subtilis. Genes Dev., 10, 
2014-2024. 
Solomon, J. M., Magnuson, R., Srivastava, A., Grossman, A. D., 1995. 
Convergent sensing pathways mediate response to two extracellular 
competence factors in Bacillus subtilis. Genes Dev., 9, 547-558. 
Stein, T., 2005. Bacillus subtilis antibiotics: structures, syntheses and specific 
functions. Molecular Microbiology, 56(4), 845-857. 
Steinborn, G., and Hofemeister, J., 1998/2000. Genes for the biosynthesis of 
anticapsin and bacilysin, their isolation and use. PCT/DE99/ 02179, 
WO 00/03009. 
Stephenson, S., Mueller, C., Jiang, M., and Perego  M., 2003. Molecular Analysis 
of Phr Peptide Processing in Bacillus subtilis.  J. Bacteriol., 185, 16, 
4861-4871. 
Stock, J. B., Ninfa, A. J., and Stock, A. M., 1989. Protein phosphorylation and 
regulation of adaptive responses in bacteria. Microbiol. Rev., 53, 450-
490. 
 
67
Stöver, A. G., and Driks, A., 1999. Regulation of synthesis of the Bacillus subtilis 
transition-phase, spore-associated antibacterial protein TasA. J. 
Bacteriol., 181, 5476-5481. 
Strauch, M. A., 1993. AbrB, a transition state regulator. In: Bacillus subtilis and 
other gram-positive bacteria: biochemistry, physiology and molecular 
genetics, (p. 757–764),  American Society for Microbiology. 
Strauch, M. A., 1993.  Regulation of Bacillus subtilis gene expression during the 
transition from exponential growth to stationary phase. Prog. Nucleic 
Acid Res. Mol. Biol., 46, 121-153. 
Strauch, M. A., and Hoch, J. A., 1993. Transition-state regulators: sentinels of 
Bacillus subtilis post-exponential gene expression. Mol. Microbiol., 7, 
337-342. 
Strauch, M. A., Bobay, B. G., Cavanagh, J.,  Yao, F., Wilson, A., and Le Breton, 
Y.. 2007. Abh and AbrB Control of Bacillus subtilis Antimicrobial 
Gene Expression. Journal of Bacteriology, Vol. 189, No. 21, 7720-
7732. 
Strauch, M.A., Webb, V., Spiegelman, G., and Hoch, J. A., 1990. The Spo0A 
protein of Bacillus subtilis is a repressor of the abrB gene. Proc. Natl. 
Acad. Sci., 87, 1801-1805. 
Tanaka, T., Kawata, M., and Mukai, K., 1991. Altered Phosphorylation of 
Bacillus subtilis DegU Caused by Single Amino Acid Changes in 
DegS. Journal of  Bacteriology, Vol. 173, No. 17, 5507-5515.  
Tomasz, A., 1965. Control of the Competent State in Pneumococcus by a Hormone-
Like Cell Product: An Example for a New Type of Regulatory 
Mechanism in Bacteria. Nature, 208, 155-159.  
Tortosa, P.,  and Dubnau, D., 1999.Competence for transformation: a matter of 
taste. Current opinion in microbiology, 2(6), 588-592. 
Trowsdale, J., Chen, S. M. H., and Hoch, J. A., 1978. Genetic analysis of 
phenotype revertants of spo0A mutants in Bacillus subtilis: a new 
cluster of ribosomal genes. In: Spores VII (pp. 131-135). American 
Society for Microbiology. 
vanSinderen, D., Withoff, S.,  Boels, H.,  and Venema, G., 1990. Isolation and 
characterization of comL, a transcription unit involved in competence 
development in Bacillus subtilis. Mol. Gen. Genet., 224, 396-404. 
vonDöhren, H., Dieckmann, R.,  and Pavela-Vrancic, M., 1999. Chem. Biol. 6, 
273-279Weinrauch, Y., Penchev, R., Dubnau, E., Smith, I., and 
Dubnau, D., 1990. A  Bacillus subtilis regulatory gene product for 
genetic competence and sporulation resembles sensor protein 
members of the bacterial two-component signal-transduction systems. 
Genes Dev., 4, 860-872.  
Waldburger, C., Gonzalez, D., and Chambliss, G. H., 1993. Characterization of a 
New Sporulation Factor in Bacillus subtilis. Journal of Bacteriology, 
Vol. 175, No. 19, 6321-6327. 
Walker, J. E., and Abraham, E. P., 1970. The structure of bacilysin and other 
products of Bacillus subtilis. Biochem. J., 118, 563-570. 
 
68
Walton, R. B., and Rickes, E. L., 1962. Reversal of the antibiotic bacillin by N-
acetylglucosamine. J Bacteriol., 84, 1148-1151. 
Weir, J., Predich, M., Dubnau, E.,  Nair, G., and Smith,  I., 1991. Regulation of 
spo0H, a gene coding for the Bacillus subtilis σH factor. J. Bacteriol., 
173, 521-529. 
Whitney, J. G.,  and Funderburk, S. S., 1970. Anticapsin, a new biologically 
active metabolite. IV. Mechanism of action. In: Abstracts for the X 
international congress for microbiology, Mexico City, p. 101. 
Whitney, J. G., Funderburk, S. S., Westhead, J. E., Lively, D. H., Solenberg, J. 
M., and Denney, J. W., 1972. Anticapsin, a New Biologically Active 
Metabolite: Screening and Assay Procedures. Applied Microbiology, 
Vol. 24, No. 6, 907-910.  
Williams, P., 2007. Quorum sensing, communication and cross-kingdom signalling 
in the bacterial world. Microbiology, 153, 3923-3938.    
Williams, P., 2007. Bacillus subtilis: A Shocking Message from a Probiotic Cell 
Host & Microbe, Vol. 1, no. 4, 248-24. 
Winans, S. C.,  and Bassler, B. L., 2002. Journal of Bacteriology, Vol. 184, no. 4, 
873-883. 
Yazgan, A., Özcengiz, G., and Marahiel, M. H., 2001. Tn 10 insertional mutations 
of Bacillus subtilis that block the biosynthesis of bacilysin. Biochim 
Biophys Acta., 1518, 87-94. 
Yazgan, A., Özcengiz, G., Özcengiz, E., Kılınc, K., Marahiel, M. A., and 
Alaeddinoğlu,  N. G., 2001. Bacilysin biosynthesis by a partially-
purified enzyme fraction from Bacillus subtilis. Enzyme Microb 
Technol., 9, 400-406. 
Yazgan-Karatas, A. Y., Cetin, S., and Özcengiz, G., 2003. The effects of 
insertional mutations in comQ, comp, srfA, spo0H, spo0A and abrB 
genes on bacilysin biosynthesis in Bacillus subtilis. Biochim Biophys 
Acta., 1626, 51-56. 
Zheng, G., Yan, L. Z., Vederas, J. C., and Zuber, P., 1999. Genes of the sbo-alb 
locus of Bacillus subtilis are required for production of the antilisterial 
bacteriocin subtilosin. J. Bacteriol., 181, 7346-7355. 
Zuber, P., Nakano, M. M., and Marahiel, M. A., 1993. Peptide antibiotics. In: 
Bacillus subtilis and Other Gram-positive Bacteria: Biochemistry, 
Physiology, and Molecular Genetics (pp. 897-916), American Society 
for Microbiology. 
 
 
69
APPENDICES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    APPENDIX A : Composition and Preperation of Culture Media 
    APPENDIX B : Composition and Preparation of  Buffers and Solutions 
    APPENDIX C : Chemicals and Enzymes 
    APPENDIX D : Markers 
    APPENDIX E : yvfI DNA  Sequence 
 
70
 
APPENDIX A 
 
Luria Bertani (LB) Agar Medium (1000 ml) 
Tryptone                             10 g/L 
Yeast Extract                        5 g/L 
NaCl2                                                            5 g/L 
Agar                                  15 g/L 
Distilled H2O was added up to 1000ml and then autoclaved for 4 minutes. 
2xYT Medium (1000ml) 
Tryptone                           16 g 
Yeast Extract                    10 g 
NaCl                                 5 g 
Agar                                    15 g  (Added before autoclaving for solid 2xYT medium) 
HS medium (30 ml) 
10X-S-base                            3 ml 
Glucose (50%)                     300 µl 
Yeast Extract (10%)             300 µl 
Casaminoacid (2%)              300 µl 
Arg (8%) + His (0.4%)           3 ml 
Tryptophan (0.5%)              300 µl 
Phenylalanine (0.3%)           450 µl 
Completed up to 30 ml with sterile distilled H2O and store at cold (+4°C) for a week. 
 
 
 
 
71
LS Medium (20 ml) 
10X-S-Base                                 2 ml 
Glucose                                    200 µl 
Tryptophan                               200 µl 
Phenylalanine                             30 µl 
Casaminoacid                            100 µl 
Yeast Extract                            200 µl 
Spermine (50mM)                     200 µl 
MgCl2 (1M) (filter steriled)          50 µl 
Freshly prepared and completed up to 20 ml with sterile distilled H2O. 
Perry and Abraham (PA) Medium (pH 7.4) 
KH2PO4                                                                1 g/L 
KCl                                        0.2 g/L 
MgSO4.7H2O*                         0.5 g/L 
Glutamate.Na.H2O                      4 g/L 
Sucrose*                                  10 g/L  
Ferric citrate**                      0.15 g/L 
Trace elements**                         1 ml 
CoCl2.6H2O                      0.0001  g/L 
Ammonium molybdate        0.0001 g/L 
MnCl2.4H2O                       0.001  g/L 
ZnSO4.7H2O                      0.0001 g/L 
CuSO4.5H2O                    0.00001 g/L 
*Autoclave separately 
**Filter sterilization 
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DSM Medium (Difco’s Sporulation Medium) 
Nutrient Broth                        8 g 
KCl (10 %  w/v)                     10 ml 
MgSO4.7H2O (1.2 %)             10 ml 
NaOH (1 M)                           0.5 ml 
Autoclaved for 30 min. and cooled own to 50 ◦C. 
Ca(NO3)4 (1 M)                      1 ml 
MnCl2 (0.01 M)                     1 ml 
FeSO4 (1 mM)                       1 ml (resuspended before use) 
1.5 % Agar was added if needed. 
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APPENDIX B 
 
P1 Buffer (pH 8) 
 
Tris-base                                                6.06 gr 
EDTA.2H2O        3.72 gr 
Dissolve Tris-base and EDTA with 800 ml dH2O. Adjust pH to 8 with HCl. Adjuste 
volume to 1 lt dH2O. Add 100 mg RNase A er liter of P1. 
P2 Buffer 
NaOH                                                     8 gr 
SDS solution (20%)                               50 ml 
Dissolve NaOH in 950 ml dH2O. Add 50 ml SDS solution. 
P3 Buffer  (pH 5.5) 
Potassium acetate                                   294.5 gr 
Dissolve in 500 ml dH2O. Adjust pH 
TE Buffer (pH 7) 
Tris base                                          10 mM 
EDTA                                               1 mM 
Adjusted pH 7 with HCl 
TAE Buffer (50X) 
Tris base (2 moles)                            242 g 
Glacial acetic acid (57.1 ml)               57.1 ml 
EDTA (100mL 0.5M)                       100 ml (0.5 M, pH 8.0) 
Add dH2O up to 1L and adjust pH to 8 by HCl 
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Low Melting Agarose Gel (1%) 
Agarose                       0.5 g 
TAE buffer (1X)          50 ml 
Add 1.5µl EtBr (final concentration: 0.5 µg/ml) before pouring the gel into tray. 
 
CTAB/NaCl Solution (10 % CTAB/ 0.7 M NaCl) 
4.1 g of NaCl was dissolved in 80 ml of dH2O. Then, 10 g of CTAB (hexadecyl 
trimethyl ammonium bromide) was added and dissolved with vigorously shaking 
and gentle heating up to 65 ° C. Final volume was made up to 100 ml with dH2O. 
 
Physiological Sodium Chloride Solution (0.85%) (1000 ml) 
NaCl2                                              8.5 g 
Dissolve in 1000 ml distilled water and autoclave. 
 
Tris-Cl Solution (25mM, 1000 ml, pH 7.4) 
Tris (hydromethyl)aminomethane              3.03 g 
Dissolve in 1000 ml distilled water and adjust pH to 7.4 with HCl (1 M). 
 
Z Buffer (500 ml, pH 7.0) 
Na2HPO4.7H2O  (60mM)                     5.33 g 
NaH2PO4                (40 mM)                      3.12 g 
KCl2                          (10 mM)                     0.373 g 
MgSO4.7H2O       (1 Mm)                  0.123 g 
All mixed and dissolved within 500 ml distilled water and the pH was adjusted to a 
value of 7.0. 
 
75
β-mercaptoethanol       :          6,75µl was added into 50 ml of Z buffer, immediately 
before using. 
Triton X-100       :      100 µl was added into  900 µl Z buffer including β-
mercaptoethanol.  
Lysozyme final concentration:                   2.5 mg/ml 
ONPG final concentration:                        4.0 mg/ml 
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APPPENDIX C 
 
Chemicals                                                                            Suppliers 
Agar Bacteriological                                                            AppliChem 
Agarose                                                                                Prona 
Ammonium persulfate                                                         Carlo Erba 
Arginine                                                                               Merck 
CaCl2.2H2O                                                                          Merck 
Casamino acid                                                                      AppliChem 
Cloramphenicol                                                                    Sigma 
CoCl2.6H2O                                                                          Carlo Erba 
CTAB                                                                                   Sigma 
CuSO4.5H2O                                                                         Carlo Erba 
EDTA                                                                                   Sigma 
Ethanol                                                                                  Botafarma 
Ethidium bromide                                                                 Sigma 
Glucose                                                                                 Riedel deHaen 
Glycerol                                                                                Merck 
HCl                                                                                       Carlo Erba 
Histidine                                                                                Merck 
IPTG                                                                                     Sigma 
K2HPO4                                                                                J.T.Baker 
KCl                                                                                       Carlo Erba 
KH2PO4                                                                                J.T.Baker 
Mercaptoethanol                                                                   Merck 
MgCl2.6H2O                                                                        Carlo Erba 
MgSO4.7H2O                                                                       Carlo Erba 
MnCl2.4H2O                                                                        Carlo Erba 
Na2CO3                                                                                Riedel deHaen  
Na3citrate.2H2O                                                                   Riedel deHaen 
NaCl                                                                                     Carlo Erba 
NaOH                                                                                   Carla Erba 
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2-Nitrophyl β-D-galacto pyranoside (ONPG)                     Sigma 
Nutrient Broth                                                                      Merck 
PEG 8000                                                                             Merck 
Phenol-chloroform-isoamylalcohol                                      Fluka 
Phenylalanin                                                                         Merck 
SDS                                                                                       Merck 
Spermine                                                                               Fluka 
Sucrose                                                                                  Merck 
Tris-base                                                                               Merck 
Triton-X100                                                                          Sigma 
Trypton                                                                                 Acumedia 
Tryptophan                                                                            Merck 
X-Gal                                                                                    Sigma  
Yeast Extract                                                                        Acumedia 
 
 
Enzymes 
BamHI                                                                                  Fermentas 
HindIII                                                                                  Fermentas 
Lysozyme                                                                             AppliChem 
Proteinase K                                                                         Sigma 
RNAse A                                                                              Sigma 
Taq DNA Polymerase                                                          Roche 
T4 DNA Ligase                                                                    Roche 
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APPENDIX D 
 
Marker                                                                                       Supplier 
Lambda DNA/EcoRI+ HindIII Marker  (Marker 3)                   MBI Fermentas 
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APPENDIX E 
 
 
 
 
yvfI DNA Sequence 
 
atgaaacagggagaaggcacgtatctgaaggaatttgagctcaatcaaatttctcagccgctctca 
gccgcccttctgatgaaaaaagaggacgtcaagcagctgctcgaggtcagaaaactgcttgaaat 
cggcgtggcttcactagcggctgaaaaaaggacagaagcagatctcgaaagaattcaggatgca 
ctaaaggaaatgggcagcattgaagcggacggggagctgggagagaaagcagactttgcatttc 
atcttgcgcttgcggacgcttctcaaaatgaacttcttaaacacttgatgaatcacgtgtcatcattgc 
tgctggaaacaatgagggaaacgaggaaaatctggctgttttccaagaagacctccgttcagcgg 
ctgtatgaggagcacgaacggatttacaatgctgtggctgccgggaacggtgcacaggcggaag 
ccgccatgctggcgcatttgacgaatgtggaagatgtgctttcgggatatttcgaggaaaatgtgca 
a 
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